StudyID;Title;Authors;Year;DOI;Journal;JIF of journal;Conflicts of interest;Antibiotics;FBS source;Glucose level;Type of untreated control;TMZ source reported?;Cell number;Cell volume;Cell concentration;Volume of added TMZ reported?;Volume of added control;Assay;Number of experiments;Errortype;Errortype reporting;U-87 MG authentication;U-87 MG source;U-87 MG age;Confluence at cell passaging;Time interval between cell passaging;Mycoplasma contamination exclusion;Treatment duration;TMZ concentration;Reporting ratio;Included in meta-analysis?;Mean cell viability;Error cell viability;Cell viability unit;Presented as growth inhibition?;Control?;Sample size calculation;Random group allocation;Blinded outcome assessment;Open-access pre-registered study protocol;Way of calculation for cell viability summary data;Unclear number of independent experiments and replications per experiment;Data presented for every experiment?;Missing data (for particular drug concentrations and/or treatment durations) within an experiment01784eb2-1068-469a-99e9-530f57b43e7d;Growth-inhibitory and chemosensitizing effects of microRNA-31 in human glioblastoma multiforme cells;Zhou et al.;2015;10.3892/ijmm.2015.2312;INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE ;2,348;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;not reported;NA;4000;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,4375;FALSE;99,7;3,2;MTT assay (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing01784eb2-1068-469a-99e9-530f57b43e7d;Growth-inhibitory and chemosensitizing effects of microRNA-31 in human glioblastoma multiforme cells;Zhou et al.;2015;10.3892/ijmm.2015.2312;INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE ;2,348;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;4000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,4375;FALSE;79,5;6,5;MTT assay (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing0758b223-36e9-49bb-b7f3-128c15808a1b;Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme;Fischer et al.;2007;10.1097/PPO.0b013e318157053f;Cancer Journal;1,673;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;1000;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SD;not reported;FALSE;colleagues;;NA;NA;FALSE;8;0;0,375;FALSE;100;4,7;Cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing0758b223-36e9-49bb-b7f3-128c15808a1b;Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme;Fischer et al.;2007;10.1097/PPO.0b013e318157053f;Cancer Journal;1,673;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;not reported;FALSE;colleagues;;NA;NA;FALSE;8;20;0,375;FALSE;54,7;12,4;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing0758b223-36e9-49bb-b7f3-128c15808a1b;Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme;Fischer et al.;2007;10.1097/PPO.0b013e318157053f;Cancer Journal;1,673;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;not reported;FALSE;colleagues;;NA;NA;FALSE;8;200;0,375;FALSE;29,4;10,3;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing0758b223-36e9-49bb-b7f3-128c15808a1b;Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme;Fischer et al.;2007;10.1097/PPO.0b013e318157053f;Cancer Journal;1,673;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;not reported;FALSE;colleagues;;NA;NA;FALSE;8;5;0,375;FALSE;92,8;10,3;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing0758b223-36e9-49bb-b7f3-128c15808a1b;Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme;Fischer et al.;2007;10.1097/PPO.0b013e318157053f;Cancer Journal;1,673;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;not reported;FALSE;colleagues;;NA;NA;FALSE;8;50;0,375;FALSE;42,3;4,7;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;10000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;0;0,5;TRUE;100;0;Cell content (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;10000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;0;0,5;TRUE;100;0;Cell content (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;10000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;0;0,5;TRUE;100;0;Cell content (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;10000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;0;0,5;TRUE;100;0;Cell content (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;10;0,5;TRUE;76,5;10;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;10;0,5;TRUE;72;14,7;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;10;0,5;TRUE;76;12;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;10;0,5;TRUE;75,8;10;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;15;0,5;TRUE;44,8;9;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;15;0,5;TRUE;58,9;14,5;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;15;0,5;TRUE;64;16;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;15;0,5;TRUE;55;9;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;2,5;0,5;TRUE;94,8;5,5;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;2,5;0,5;TRUE;97;5;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;20;0,5;TRUE;46,5;11,5;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;20;0,5;TRUE;46;12;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;5;0,5;TRUE;87,3;1;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;5;0,5;TRUE;91,2;5,5;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;5;0,5;TRUE;92;6;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing07639453-4cdd-4a54-add6-4a7d382fc5dc;In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells;Tzadok et al.;2010;10.3892/ijo-00000756;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;FALSE;10000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;7;5;0,5;TRUE;87,6;1;Cell content (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;0;0,5;TRUE;100;1;Viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;0,25;0,5;TRUE;98,3;1;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;0,5;0,5;TRUE;95,8;1,8;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;100;0,5;TRUE;28;1;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;2,5;0,5;TRUE;92,3;1;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;200;0,5;TRUE;16,1;1;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;25;0,5;TRUE;63,6;1,8;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;5;0,5;TRUE;84,4;1,8;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;50;0,5;TRUE;47,8;1;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing086dce0d-1142-4bf2-bd43-9533e23bfb18;Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line;Ashizawa et al.;2014;10.3892/ijo.2014.2439;INTERNATIONAL JOURNAL OF ONCOLOGY;3,025;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;not reported;FALSE;ATCC;20;NA;NA;FALSE;4;500;0,5;TRUE;10,2;1;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing0a8024aa-6d58-43b2-96ea-61543cae0549;Synergistic combination of chemo-phototherapy based on temozolomide/ICG-loaded iron oxide nanoparticles for brain cancer treatment;Kwon et al.;2019;10.3892/or.2019.7289;Oncology reports;3,417;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;WST-1 assay, colorimetric;3;SD;reported;TRUE;other;;NA;80;FALSE;0;0;0,625;FALSE;100;0,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing0a8024aa-6d58-43b2-96ea-61543cae0549;Synergistic combination of chemo-phototherapy based on temozolomide/ICG-loaded iron oxide nanoparticles for brain cancer treatment;Kwon et al.;2019;10.3892/or.2019.7289;Oncology reports;3,417;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SD;reported;TRUE;other;;NA;80;FALSE;0;33,99415919;0,625;FALSE;91,9;3,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing0bcb0299-c385-4142-93f6-6ee7d5767ee6;Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner;Vlachostergios et al.;2013;10.1007/s10637-013-9968-1;Investigational New Drugs;2,927;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;no glucose;medium without DMSO;NA;200000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;TRUE;other;10;NA;NA;FALSE;0,667;0;0,625;TRUE;100;0,5;Cell proliferation (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing0bcb0299-c385-4142-93f6-6ee7d5767ee6;Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner;Vlachostergios et al.;2013;10.1007/s10637-013-9968-1;Investigational New Drugs;2,927;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;no glucose;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;other;10;NA;NA;FALSE;0,667;100;0,625;TRUE;71;4;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing0bf1cda2-d9a8-491b-9086-af32efd2810a;Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas;He et al.;2015;10.1097/CAD.0000000000000197;Anticancer Drugs ;2,268;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;DMSO;NA;50000;NA;NA;NA;FALSE;CCK8, colorimetric;10;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,5625;TRUE;100;0;Cell viability (% of vehicle control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing0bf1cda2-d9a8-491b-9086-af32efd2810a;Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas;He et al.;2015;10.1097/CAD.0000000000000197;Anticancer Drugs ;2,268;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;50000;NA;NA;FALSE;NA;CCK8, colorimetric;10;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;0,4;0,5625;TRUE;96;3;Cell viability (% of vehicle control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing0bf1cda2-d9a8-491b-9086-af32efd2810a;Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas;He et al.;2015;10.1097/CAD.0000000000000197;Anticancer Drugs ;2,268;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;50000;NA;NA;FALSE;NA;CCK8, colorimetric;10;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;4;0,5625;TRUE;91;3;Cell viability (% of vehicle control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing0bf1cda2-d9a8-491b-9086-af32efd2810a;Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas;He et al.;2015;10.1097/CAD.0000000000000197;Anticancer Drugs ;2,268;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;50000;NA;NA;FALSE;NA;CCK8, colorimetric;10;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;40;0,5625;TRUE;72;3;Cell viability (% of vehicle control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1e165179-cc1f-4fef-bbdb-97756651583d;Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis;Liu et al.;2015;10.1007/s13277-015-4503-y;TUMOR BIOLOGY;2,926;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;Temozolomide is the control group of the experiment;FALSE;3000;NA;NA;FALSE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;1;200;0,4375;FALSE;0,2;0,03;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1e165179-cc1f-4fef-bbdb-97756651583d;Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis;Liu et al.;2015;10.1007/s13277-015-4503-y;TUMOR BIOLOGY;2,926;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;Temozolomide is the control group of the experiment;FALSE;3000;NA;NA;FALSE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;2;200;0,4375;FALSE;0,25;0,04;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1e165179-cc1f-4fef-bbdb-97756651583d;Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis;Liu et al.;2015;10.1007/s13277-015-4503-y;TUMOR BIOLOGY;2,926;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;Temozolomide is the control group of the experiment;FALSE;3000;NA;NA;FALSE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;200;0,4375;FALSE;0,34;0,05;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1e165179-cc1f-4fef-bbdb-97756651583d;Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis;Liu et al.;2015;10.1007/s13277-015-4503-y;TUMOR BIOLOGY;2,926;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;Temozolomide is the control group of the experiment;FALSE;3000;NA;NA;FALSE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;4;200;0,4375;FALSE;0,51;0,05;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1ef05e18-9607-4927-9137-69fd633b2773;Growth-inhibitory and chemosensitizing effects of the glutathione-S- transferase-pi-activated nitric oxide donor PABA/NO in malignant gliomas;Kogias et al.;2012;10.1002/ijc.26106;INTERNATIONAL JOURNAL OF CANCER;6,198;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;NA;NA;FALSE;FALSE;MTT, colorimetric;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;NA;1;0,375;FALSE;NA;NA;Cell viability (percent (%) of the cell viability in the control group set to 100%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing1ff23659-a3b2-41fd-80ea-4116183d0f15;Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity and Sensitizes Glioma Cells to Temozolomide;Pang et al.;2019;10.1155/2019/1805635;Oxidative Medicine and Cellular Longevity;5,076;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;0;0,5625;TRUE;99;1;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1ff23659-a3b2-41fd-80ea-4116183d0f15;Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity and Sensitizes Glioma Cells to Temozolomide;Pang et al.;2019;10.1155/2019/1805635;Oxidative Medicine and Cellular Longevity;5,076;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;120;0,5625;TRUE;76,5;3,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1ff23659-a3b2-41fd-80ea-4116183d0f15;Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity and Sensitizes Glioma Cells to Temozolomide;Pang et al.;2019;10.1155/2019/1805635;Oxidative Medicine and Cellular Longevity;5,076;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;150;0,5625;TRUE;70,5;2,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1ff23659-a3b2-41fd-80ea-4116183d0f15;Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity and Sensitizes Glioma Cells to Temozolomide;Pang et al.;2019;10.1155/2019/1805635;Oxidative Medicine and Cellular Longevity;5,076;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;30;0,5625;TRUE;95,5;1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1ff23659-a3b2-41fd-80ea-4116183d0f15;Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity and Sensitizes Glioma Cells to Temozolomide;Pang et al.;2019;10.1155/2019/1805635;Oxidative Medicine and Cellular Longevity;5,076;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;60;0,5625;TRUE;89;5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing1ff23659-a3b2-41fd-80ea-4116183d0f15;Polyphyllin VII Promotes Apoptosis and Autophagic Cell Death via ROS-Inhibited AKT Activity and Sensitizes Glioma Cells to Temozolomide;Pang et al.;2019;10.1155/2019/1805635;Oxidative Medicine and Cellular Longevity;5,076;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;90;0,5625;TRUE;82;7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing22d86549-4c32-417f-b3a6-4af9ba1dcb23;Zinc enhances TMZ cytotoxicity in glioblastoma multiforme model system;Toren et al.;2016;10.1093/neuonc/not176;Oncotarget;6,359;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;800;NA;NA;NA;FALSE;MTT, colorimetric;6;SD;reported;TRUE;colleagues;;NA;NA;FALSE;0;0;0,5;TRUE;1;0,07;Relative Cell Viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing22d86549-4c32-417f-b3a6-4af9ba1dcb23;Zinc enhances TMZ cytotoxicity in glioblastoma multiforme model system;Toren et al.;2016;10.1093/neuonc/not176;Oncotarget;6,359;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;2500;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;TRUE;colleagues;;NA;NA;FALSE;4,5;0;0,5;TRUE;100;1,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing22d86549-4c32-417f-b3a6-4af9ba1dcb23;Zinc enhances TMZ cytotoxicity in glioblastoma multiforme model system;Toren et al.;2016;10.1093/neuonc/not176;Oncotarget;6,359;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;800;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;TRUE;colleagues;;NA;NA;FALSE;0;50;0,5;TRUE;0,69;0,09;Relative Cell Viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing22d86549-4c32-417f-b3a6-4af9ba1dcb23;Zinc enhances TMZ cytotoxicity in glioblastoma multiforme model system;Toren et al.;2016;10.1093/neuonc/not176;Oncotarget;6,359;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;2500;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;TRUE;colleagues;;NA;NA;FALSE;4,5;50;0,5;TRUE;20;2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing29c27c2f-6689-4843-9d70-45705f4d8a55;Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells;Castro et al.;2014;10.1007/s12192-014-0537-0;Cell Stress and Chaperones;3,163;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;1;0;0,5;TRUE;100;1;Viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing29c27c2f-6689-4843-9d70-45705f4d8a55;Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells;Castro et al.;2014;10.1007/s12192-014-0537-0;Cell Stress and Chaperones;3,163;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;1;10;0,5;TRUE;66;1;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing29c27c2f-6689-4843-9d70-45705f4d8a55;Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells;Castro et al.;2014;10.1007/s12192-014-0537-0;Cell Stress and Chaperones;3,163;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;1;100;0,5;TRUE;62;3;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing29c27c2f-6689-4843-9d70-45705f4d8a55;Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells;Castro et al.;2014;10.1007/s12192-014-0537-0;Cell Stress and Chaperones;3,163;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;1;25;0,5;TRUE;85;1;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing29c27c2f-6689-4843-9d70-45705f4d8a55;Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells;Castro et al.;2014;10.1007/s12192-014-0537-0;Cell Stress and Chaperones;3,163;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;1;50;0,5;TRUE;70;5;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing29c27c2f-6689-4843-9d70-45705f4d8a55;Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells;Castro et al.;2014;10.1007/s12192-014-0537-0;Cell Stress and Chaperones;3,163;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;1;500;0,5;TRUE;37;3;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing29c27c2f-6689-4843-9d70-45705f4d8a55;Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells;Castro et al.;2014;10.1007/s12192-014-0537-0;Cell Stress and Chaperones;3,163;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;colleagues;;NA;NA;FALSE;1;75;0,5;TRUE;64;3;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing2dd2d18e-08e0-4d30-9a82-9d28043244c8;Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27;Sang et al.;2014;10.1038/aps.2014.22;Acta Pharmacologica Sinica;2,912;not reported at all;Penicillin + Streptomycin;not reported;not reported;DMSO;NA;5000;200;25;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,5;TRUE;1;0,04;Relative cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing2dd2d18e-08e0-4d30-9a82-9d28043244c8;Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27;Sang et al.;2014;10.1038/aps.2014.22;Acta Pharmacologica Sinica;2,912;not reported at all;Penicillin + Streptomycin;not reported;not reported;;FALSE;5000;200;25;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;100;0,5;TRUE;0,98;0,08;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing2dd2d18e-08e0-4d30-9a82-9d28043244c8;Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27;Sang et al.;2014;10.1038/aps.2014.22;Acta Pharmacologica Sinica;2,912;not reported at all;Penicillin + Streptomycin;not reported;not reported;;FALSE;5000;200;25;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;200;0,5;TRUE;0,81;0,05;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing2dd2d18e-08e0-4d30-9a82-9d28043244c8;Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27;Sang et al.;2014;10.1038/aps.2014.22;Acta Pharmacologica Sinica;2,912;not reported at all;Penicillin + Streptomycin;not reported;not reported;;FALSE;5000;200;25;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;400;0,5;TRUE;0,67;0,04;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing31268e7c-5b50-47cb-81cd-65a249bedf43;Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling;Hanif et al.;2018;10.1016/j.tiv.2018.07.001;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;not reported;not reported;DMSO;TRUE;3000;100;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,625;TRUE;18;1;% Growth inhibition;TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing31268e7c-5b50-47cb-81cd-65a249bedf43;Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling;Hanif et al.;2018;10.1016/j.tiv.2018.07.001;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;not reported;not reported;DMSO;TRUE;3000;100;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;200;0,625;TRUE;41;1;% Growth inhibition;TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing31268e7c-5b50-47cb-81cd-65a249bedf43;Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling;Hanif et al.;2018;10.1016/j.tiv.2018.07.001;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;not reported;not reported;DMSO;TRUE;3000;100;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;25;0,625;TRUE;6;2;% Growth inhibition;TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing31268e7c-5b50-47cb-81cd-65a249bedf43;Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling;Hanif et al.;2018;10.1016/j.tiv.2018.07.001;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;not reported;not reported;DMSO;TRUE;3000;100;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;400;0,625;TRUE;46;2;% Growth inhibition;TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing31268e7c-5b50-47cb-81cd-65a249bedf43;Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling;Hanif et al.;2018;10.1016/j.tiv.2018.07.001;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;not reported;not reported;DMSO;TRUE;3000;100;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;50;0,625;TRUE;13;1;% Growth inhibition;TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing31268e7c-5b50-47cb-81cd-65a249bedf43;Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling;Hanif et al.;2018;10.1016/j.tiv.2018.07.001;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;not reported;not reported;DMSO;TRUE;3000;100;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;500;0,625;TRUE;53;2;% Growth inhibition;TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing31268e7c-5b50-47cb-81cd-65a249bedf43;Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling;Hanif et al.;2018;10.1016/j.tiv.2018.07.001;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;not reported;not reported;DMSO;NA;3000;100;30;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,625;TRUE;1;1;% Growth inhibition;TRUE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing328a9e48-df61-4a25-bff9-ed2c9cb6edb8;Temozolomide Gemcitabine and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells;Sahli et al.;2020;10.1021/acs.jmedchem.0c00694;JOURNAL OF MEDICINAL CHEMISTRY;6,205;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;medium without DMSO;NA;4400;NA;NA;NA;TRUE;Trypan Blue exclusion, cell counting;not reported;SD;not reported;FALSE;other;;NA;NA;FALSE;3;0;0,4375;FALSE;1,79;0,07;Proliferation (number of cells per mL/10^6);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing328a9e48-df61-4a25-bff9-ed2c9cb6edb8;Temozolomide Gemcitabine and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells;Sahli et al.;2020;10.1021/acs.jmedchem.0c00694;JOURNAL OF MEDICINAL CHEMISTRY;6,205;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;4400;NA;NA;TRUE;NA;Trypan Blue exclusion, cell counting;not reported;SD;not reported;FALSE;other;;NA;NA;FALSE;3;10000;0,4375;FALSE;1,63;0,04;Proliferation (number of cells per mL/10^6);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing35c0a928-2ad6-4912-919e-46eab215fafb;Gene expression profiling predicts response to temozolomide in malignant gliomas;Yoshino et al.;2010;10.3892/ijo_00000621;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;medium without DMSO;NA;NA;NA;NA;NA;FALSE;other;4;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,375;TRUE;100;0;% of control;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing35c0a928-2ad6-4912-919e-46eab215fafb;Gene expression profiling predicts response to temozolomide in malignant gliomas;Yoshino et al.;2010;10.3892/ijo_00000621;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;other;4;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;0,1;0,375;TRUE;83,2;1;% of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing35c0a928-2ad6-4912-919e-46eab215fafb;Gene expression profiling predicts response to temozolomide in malignant gliomas;Yoshino et al.;2010;10.3892/ijo_00000621;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;other;4;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;1;0,375;TRUE;87,3;1;% of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing35c0a928-2ad6-4912-919e-46eab215fafb;Gene expression profiling predicts response to temozolomide in malignant gliomas;Yoshino et al.;2010;10.3892/ijo_00000621;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;other;4;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;10;0,375;TRUE;61,6;1;% of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing35c0a928-2ad6-4912-919e-46eab215fafb;Gene expression profiling predicts response to temozolomide in malignant gliomas;Yoshino et al.;2010;10.3892/ijo_00000621;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;other;4;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,375;TRUE;23,3;1;% of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing35c0a928-2ad6-4912-919e-46eab215fafb;Gene expression profiling predicts response to temozolomide in malignant gliomas;Yoshino et al.;2010;10.3892/ijo_00000621;INTERNATIONAL JOURNAL OF ONCOLOGY;2,571;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;other;4;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;1000;0,375;TRUE;8,2;1;% of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing35e10def-f7d7-4c8c-a02b-922b44510337;MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma;Costa et al.;2013;10.1093/hmg/dds496;Human Molecular Genetics;6,677;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;35000;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,5625;TRUE;100;0,5;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing35e10def-f7d7-4c8c-a02b-922b44510337;MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma;Costa et al.;2013;10.1093/hmg/dds496;Human Molecular Genetics;6,677;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;DMSO;NA;35000;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,5625;TRUE;105,6;5,8;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing35e10def-f7d7-4c8c-a02b-922b44510337;MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma;Costa et al.;2013;10.1093/hmg/dds496;Human Molecular Genetics;6,677;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;35000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;1;0,5625;TRUE;103,7;6,2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing35e10def-f7d7-4c8c-a02b-922b44510337;MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma;Costa et al.;2013;10.1093/hmg/dds496;Human Molecular Genetics;6,677;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;35000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;10;0,5625;TRUE;85;13;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing35e10def-f7d7-4c8c-a02b-922b44510337;MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma;Costa et al.;2013;10.1093/hmg/dds496;Human Molecular Genetics;6,677;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;35000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,5625;TRUE;72;3,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing35e10def-f7d7-4c8c-a02b-922b44510337;MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma;Costa et al.;2013;10.1093/hmg/dds496;Human Molecular Genetics;6,677;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;35000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;20;0,5625;TRUE;87,9;3,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing35e10def-f7d7-4c8c-a02b-922b44510337;MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma;Costa et al.;2013;10.1093/hmg/dds496;Human Molecular Genetics;6,677;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;35000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;5;0,5625;TRUE;94,6;4,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing35e10def-f7d7-4c8c-a02b-922b44510337;MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma;Costa et al.;2013;10.1093/hmg/dds496;Human Molecular Genetics;6,677;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;35000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;50;0,5625;TRUE;72,5;7,2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;not reported;NA;2500;NA;NA;NA;FALSE;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;1;0;0,625;TRUE;100;4;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;not reported;NA;2500;NA;NA;NA;FALSE;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;2;0;0,625;TRUE;100;1,2;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;not reported;NA;2500;NA;NA;NA;FALSE;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;0;0,625;TRUE;100;1,9;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;1;1;0,625;TRUE;94,9;4,8;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;2;1;0,625;TRUE;103,5;1,7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;1;0,625;TRUE;105,8;3,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;1;10;0,625;TRUE;93,8;4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;2;10;0,625;TRUE;102,4;2,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;10;0,625;TRUE;109,2;3,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;1;100;0,625;TRUE;86,4;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;2;100;0,625;TRUE;92;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;100;0,625;TRUE;94,4;2,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;1;5;0,625;TRUE;98,2;4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;2;5;0,625;TRUE;102,4;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;5;0,625;TRUE;109,4;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;1;50;0,625;TRUE;88;4,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;2;50;0,625;TRUE;99,5;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing36e240d7-a03b-4879-afc8-a484f9e8ba4e;MIM1 the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells;Respondek et al.;2018;10.1016/j.tiv.2018.08.007;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;other;Other source;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;50;0,625;TRUE;105,2;3;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3791e67c-f846-43b9-be72-6f3711359c63;?-Elemene inhibits proliferation through crosstalk between glia maturation factor ? and extracellular signal-regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells;Zhu et al.;2014;10.3892/mmr.2014.2273;MOLECULAR MEDICINE REPORTS ;1,554;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;0;0,5;TRUE;100;4;Viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3791e67c-f846-43b9-be72-6f3711359c63;?-Elemene inhibits proliferation through crosstalk between glia maturation factor ? and extracellular signal-regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells;Zhu et al.;2014;10.3892/mmr.2014.2273;MOLECULAR MEDICINE REPORTS ;1,554;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;300;0,5;TRUE;60;5;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing399b4c31-88e5-4430-8324-090dc87864db;Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma;Rodriguez de Anda et al.;2019;10.1002/jbm.b.34324;JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS ;2,831;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;medium without DMSO;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;4;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,625;TRUE;104,2;3,3;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing399b4c31-88e5-4430-8324-090dc87864db;Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma;Rodriguez de Anda et al.;2019;10.1002/jbm.b.34324;JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS ;2,831;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;4;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,625;TRUE;102;8,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing399b4c31-88e5-4430-8324-090dc87864db;Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma;Rodriguez de Anda et al.;2019;10.1002/jbm.b.34324;JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS ;2,831;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;4;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;1000;0,625;TRUE;63,5;7,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing399b4c31-88e5-4430-8324-090dc87864db;Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma;Rodriguez de Anda et al.;2019;10.1002/jbm.b.34324;JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS ;2,831;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;4;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;200;0,625;TRUE;82,6;8,3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing399b4c31-88e5-4430-8324-090dc87864db;Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma;Rodriguez de Anda et al.;2019;10.1002/jbm.b.34324;JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS ;2,831;not reported at all;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;4;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;500;0,625;TRUE;64,4;7,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;0;0,4375;FALSE;100;0;Cell growth (%) (s normalized to the untreated control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;0;0;0,4375;FALSE;0,03;0,02;Cell growth (%) (s normalized to the untreated control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;6;0;0,4375;FALSE;0,28;0,02;Cell growth (%) (s normalized to the untreated control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;0;0,4375;FALSE;0,88;0,02;Cell growth (%) (s normalized to the untreated control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;128;0,4375;FALSE;16;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;16;0,4375;FALSE;35,5;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;1;2;0,4375;FALSE;97;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;256;0,4375;FALSE;15;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;32;0,4375;FALSE;21,5;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;4;0,4375;FALSE;88,5;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;0;5;0,4375;FALSE;0,02;0,02;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;6;5;0,4375;FALSE;0,26;0,02;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;5;0,4375;FALSE;0,68;0,02;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;512;0,4375;FALSE;12,5;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;64;0,4375;FALSE;16;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3b27a4cf-4334-48f3-a0ff-0368092c00ec;Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma;Renziehausen et al.;2019;10.1158/1535-7163.MCT-18-1250;MOLECULAR CANCER THERAPEUTICS ;5,615;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;not reported;SEM;reported;FALSE;ATCC;20;NA;NA;TRUE;9;8;0,4375;FALSE;63;3;Cell growth (%) (s normalized to the untreated control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing3c41250d-a6ef-47cd-bdce-1323921aa009;Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide;Messaoudi et al.;2014;10.2147/IJN.S59134;International Journal of Nanomedicine ;4,383;it is reported that there are no conflicts of interest ;not reported;not reported;low glucose & pyruvate;not reported;NA;25000;500;50;NA;FALSE;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,4375;FALSE;100;8;% of living cells;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3c41250d-a6ef-47cd-bdce-1323921aa009;Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide;Messaoudi et al.;2014;10.2147/IJN.S59134;International Journal of Nanomedicine ;4,383;it is reported that there are no conflicts of interest ;not reported;not reported;low glucose & pyruvate;;FALSE;25000;500;50;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;154,5189054;0,4375;FALSE;99;6;% of living cells;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3c41250d-a6ef-47cd-bdce-1323921aa009;Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide;Messaoudi et al.;2014;10.2147/IJN.S59134;International Journal of Nanomedicine ;4,383;it is reported that there are no conflicts of interest ;not reported;not reported;low glucose & pyruvate;;FALSE;25000;500;50;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;309,0378108;0,4375;FALSE;89;11;% of living cells;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3c41250d-a6ef-47cd-bdce-1323921aa009;Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide;Messaoudi et al.;2014;10.2147/IJN.S59134;International Journal of Nanomedicine ;4,383;it is reported that there are no conflicts of interest ;not reported;not reported;low glucose & pyruvate;;FALSE;25000;500;50;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;643,8287725;0,4375;FALSE;85;8;% of living cells;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3c41250d-a6ef-47cd-bdce-1323921aa009;Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide;Messaoudi et al.;2014;10.2147/IJN.S59134;International Journal of Nanomedicine ;4,383;it is reported that there are no conflicts of interest ;not reported;not reported;low glucose & pyruvate;;FALSE;25000;500;50;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;1287,657545;0,4375;FALSE;75;4;% of living cells;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3c41250d-a6ef-47cd-bdce-1323921aa009;Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide;Messaoudi et al.;2014;10.2147/IJN.S59134;International Journal of Nanomedicine ;4,383;it is reported that there are no conflicts of interest ;not reported;not reported;low glucose & pyruvate;;FALSE;25000;500;50;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;2575,31509;0,4375;FALSE;69;7;% of living cells;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3dbdbe41-d0eb-48c1-b17f-220b052d1937;Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo;Chakrabarti et al.;2015;10.1007/s10495-015-1198-x;Apoptosis;3,592;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,5;TRUE;100;2,7;" Cell viability (% of control; OD at 570nm)";FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing3dbdbe41-d0eb-48c1-b17f-220b052d1937;Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo;Chakrabarti et al.;2015;10.1007/s10495-015-1198-x;Apoptosis;3,592;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,5;TRUE;58,4;5,9;" Cell viability (% of control; OD at 570nm)";FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing3eedd5d4-fa1a-4ae8-ad65-8cab83302689;Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines;Karpel-Massler et al.;2014;10.2174/18715206113136660340;Anti-Cancer Agents in Medicinal Chemistry;2,469;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;Temozolomide is the control group of the experiment;TRUE;1500;NA;NA;FALSE;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;12,2;0,5625;TRUE;78;12;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing3eedd5d4-fa1a-4ae8-ad65-8cab83302689;Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines;Karpel-Massler et al.;2014;10.2174/18715206113136660340;Anti-Cancer Agents in Medicinal Chemistry;2,469;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;Temozolomide is the control group of the experiment;TRUE;1500;NA;NA;FALSE;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;20,5;0,5625;TRUE;60;18;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,5625;TRUE;155,5;10;Cell number *1000;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;0;0,5625;TRUE;0,68;0,08;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,5625;TRUE;0,93;0,04;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5625;TRUE;1;0,05;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;4;0;0,5625;TRUE;1,36;0,06;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,5625;TRUE;100;5;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;70;0,5625;TRUE;84,5;4;Cell number *1000;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;70;0,5625;TRUE;0,6;0,04;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;70;0,5625;TRUE;0,74;0,08;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;70;0,5625;TRUE;0,82;0,09;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;4;70;0,5625;TRUE;1,03;0,09;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing41561b20-5972-4095-aa53-32465f12d018;Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling;Han et al.;2017;10.1038/bjc.2017.89;British Journal of Cancer;5,922;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;70;0,5625;TRUE;60,5;6;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing427b652e-42e6-436e-bbd4-387c914bca80;Combination of biochanin a and temozolomide impairs tumor growth by modulating cell metabolism in glioblastoma multiforme;Desai et al.;2019;10.21873/anticanres.13079;ANTICANCER RESEARCH;1,994;not reported at all;not reported;Other source;not reported;not reported;NA;10000;NA;NA;NA;FALSE;other;3;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,375;TRUE;100;1; cell survival (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing427b652e-42e6-436e-bbd4-387c914bca80;Combination of biochanin a and temozolomide impairs tumor growth by modulating cell metabolism in glioblastoma multiforme;Desai et al.;2019;10.21873/anticanres.13079;ANTICANCER RESEARCH;1,994;not reported at all;not reported;Other source;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,375;TRUE;100;0,5;cell survival (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing427b652e-42e6-436e-bbd4-387c914bca80;Combination of biochanin a and temozolomide impairs tumor growth by modulating cell metabolism in glioblastoma multiforme;Desai et al.;2019;10.21873/anticanres.13079;ANTICANCER RESEARCH;1,994;not reported at all;not reported;Other source;not reported;;TRUE;10000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;20;0,375;TRUE;79;6; cell survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing427b652e-42e6-436e-bbd4-387c914bca80;Combination of biochanin a and temozolomide impairs tumor growth by modulating cell metabolism in glioblastoma multiforme;Desai et al.;2019;10.21873/anticanres.13079;ANTICANCER RESEARCH;1,994;not reported at all;not reported;Other source;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;20;0,375;TRUE;79,4;6,2;cell survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing427b652e-42e6-436e-bbd4-387c914bca80;Combination of biochanin a and temozolomide impairs tumor growth by modulating cell metabolism in glioblastoma multiforme;Desai et al.;2019;10.21873/anticanres.13079;ANTICANCER RESEARCH;1,994;not reported at all;not reported;Other source;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,375;TRUE;85,5;17,6;cell survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing427b652e-42e6-436e-bbd4-387c914bca80;Combination of biochanin a and temozolomide impairs tumor growth by modulating cell metabolism in glioblastoma multiforme;Desai et al.;2019;10.21873/anticanres.13079;ANTICANCER RESEARCH;1,994;not reported at all;not reported;Other source;not reported;;TRUE;10000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;70;0,375;TRUE;73;6; cell survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing427b652e-42e6-436e-bbd4-387c914bca80;Combination of biochanin a and temozolomide impairs tumor growth by modulating cell metabolism in glioblastoma multiforme;Desai et al.;2019;10.21873/anticanres.13079;ANTICANCER RESEARCH;1,994;not reported at all;not reported;Other source;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;3;70;0,375;TRUE;72;5,7;cell survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing4460c6e8-45ac-4cf5-9d06-ebbdaafb7912;Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma;Yamini et al.;2004;10.1158/0008-5472.CAN-04-2117;CANCER RESEARCH;7,69;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTS, colorimetric;3;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;0;0,5;TRUE;1,2;0,09;OD Absorbance (490nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4460c6e8-45ac-4cf5-9d06-ebbdaafb7912;Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma;Yamini et al.;2004;10.1158/0008-5472.CAN-04-2117;CANCER RESEARCH;7,69;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;10000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;0;0,5;TRUE;94,6;0,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4460c6e8-45ac-4cf5-9d06-ebbdaafb7912;Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma;Yamini et al.;2004;10.1158/0008-5472.CAN-04-2117;CANCER RESEARCH;7,69;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;10000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;0;0,5;TRUE;96,3;0,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4460c6e8-45ac-4cf5-9d06-ebbdaafb7912;Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma;Yamini et al.;2004;10.1158/0008-5472.CAN-04-2117;CANCER RESEARCH;7,69;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;10000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;0;0,5;TRUE;90,9;0,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4460c6e8-45ac-4cf5-9d06-ebbdaafb7912;Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma;Yamini et al.;2004;10.1158/0008-5472.CAN-04-2117;CANCER RESEARCH;7,69;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;100;0,5;TRUE;1;0,09;OD Absorbance (490nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4460c6e8-45ac-4cf5-9d06-ebbdaafb7912;Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma;Yamini et al.;2004;10.1158/0008-5472.CAN-04-2117;CANCER RESEARCH;7,69;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;100;0,5;TRUE;92,3;0,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4460c6e8-45ac-4cf5-9d06-ebbdaafb7912;Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma;Yamini et al.;2004;10.1158/0008-5472.CAN-04-2117;CANCER RESEARCH;7,69;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;100;0,5;TRUE;90,9;0,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4460c6e8-45ac-4cf5-9d06-ebbdaafb7912;Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma;Yamini et al.;2004;10.1158/0008-5472.CAN-04-2117;CANCER RESEARCH;7,69;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;100;0,5;TRUE;74,3;0,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing48a8b193-0684-4a6b-b3bc-47f74d80bd32;Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway;He et al.;2018;10.1002/ar.23839;THE ANATOMICAL RECORD;1,329;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;not reported;NA;8000;200;40;NA;FALSE;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;70;FALSE;1;0;0,5625;TRUE;1;0,04;Cell Viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing48a8b193-0684-4a6b-b3bc-47f74d80bd32;Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway;He et al.;2018;10.1002/ar.23839;THE ANATOMICAL RECORD;1,329;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;8000;200;40;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;70;FALSE;1;100;0,5625;TRUE;0,89;0,05;Cell Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing48a8b193-0684-4a6b-b3bc-47f74d80bd32;Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway;He et al.;2018;10.1002/ar.23839;THE ANATOMICAL RECORD;1,329;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;8000;200;40;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;70;FALSE;1;1600;0,5625;TRUE;0,38;0,07;Cell Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing48a8b193-0684-4a6b-b3bc-47f74d80bd32;Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway;He et al.;2018;10.1002/ar.23839;THE ANATOMICAL RECORD;1,329;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;8000;200;40;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;70;FALSE;1;200;0,5625;TRUE;0,79;0,03;Cell Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing48a8b193-0684-4a6b-b3bc-47f74d80bd32;Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway;He et al.;2018;10.1002/ar.23839;THE ANATOMICAL RECORD;1,329;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;8000;200;40;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;70;FALSE;1;400;0,5625;TRUE;0,54;0,06;Cell Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing48a8b193-0684-4a6b-b3bc-47f74d80bd32;Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway;He et al.;2018;10.1002/ar.23839;THE ANATOMICAL RECORD;1,329;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;8000;200;40;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;70;FALSE;1;50;0,5625;TRUE;0,94;0,05;Cell Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing48a8b193-0684-4a6b-b3bc-47f74d80bd32;Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway;He et al.;2018;10.1002/ar.23839;THE ANATOMICAL RECORD;1,329;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;8000;200;40;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;70;FALSE;1;800;0,5625;TRUE;0,41;0,05;Cell Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;0;0,625;FALSE;100;0,5;Cell proliferation (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;0;0,625;FALSE;99;0,5;Cell proliferation (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;0;0,625;FALSE;98;0,5;Cell proliferation (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;1000;0,625;FALSE;62,3;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;1000;0,625;FALSE;41,7;1;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;1000;0,625;FALSE;34,4;0,8;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;200;0,625;FALSE;94,4;0,8;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;200;0,625;FALSE;89,4;0,8;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;200;0,625;FALSE;72,7;2,2;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;300;0,625;FALSE;92;0,5;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;300;0,625;FALSE;85,5;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;300;0,625;FALSE;62,3;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;400;0,625;FALSE;91,7;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;400;0,625;FALSE;83,9;1,7;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;400;0,625;FALSE;62,8;1,7;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;500;0,625;FALSE;87,3;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;500;0,625;FALSE;76,8;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;500;0,625;FALSE;56;3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;600;0,625;FALSE;83,3;1,7;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;600;0,625;FALSE;71,2;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;600;0,625;FALSE;55;1;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;700;0,625;FALSE;78,4;1,7;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;700;0,625;FALSE;59,4;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;700;0,625;FALSE;50,5;1;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;800;0,625;FALSE;71,7;0,8;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;800;0,625;FALSE;52,8;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;800;0,625;FALSE;42,8;1;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;1;900;0,625;FALSE;69,4;1,7;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;2;900;0,625;FALSE;46,7;1,3;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4b98515f-057a-4d17-af4a-527e9b58ec36;Effects of galbanic acid on proliferation migration and apoptosis of glioblastoma cells through PI3K/Akt/mTOR signaling pathway;Shahcheraghi et al.;2020;10.2174/1874467213666200512075507;Current Molecular Pharmacology;3,283;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;other;3;NA;NA;FALSE;3;900;0,625;FALSE;36,3;0,5;Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing4f7e8b69-fe49-476a-bf2c-b8e84d4229ba;Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy;Qian et al.;2012;10.1021/mp3002039;MOLECULAR PHARMACEUTICS;4,57;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;22,5;0,5;TRUE;58;2;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f7e8b69-fe49-476a-bf2c-b8e84d4229ba;Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy;Qian et al.;2012;10.1021/mp3002039;MOLECULAR PHARMACEUTICS;4,57;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;4000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5;TRUE;100;0;Viable cells (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f7e8b69-fe49-476a-bf2c-b8e84d4229ba;Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy;Qian et al.;2012;10.1021/mp3002039;MOLECULAR PHARMACEUTICS;4,57;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;1875;0,5;TRUE;79;1,01;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f7e8b69-fe49-476a-bf2c-b8e84d4229ba;Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy;Qian et al.;2012;10.1021/mp3002039;MOLECULAR PHARMACEUTICS;4,57;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;15;0,5;TRUE;60,1;2,5;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f7e8b69-fe49-476a-bf2c-b8e84d4229ba;Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy;Qian et al.;2012;10.1021/mp3002039;MOLECULAR PHARMACEUTICS;4,57;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;15;0,5;TRUE;63;1;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f7e8b69-fe49-476a-bf2c-b8e84d4229ba;Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy;Qian et al.;2012;10.1021/mp3002039;MOLECULAR PHARMACEUTICS;4,57;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;30;0,5;TRUE;26,3;2,7;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f7e8b69-fe49-476a-bf2c-b8e84d4229ba;Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy;Qian et al.;2012;10.1021/mp3002039;MOLECULAR PHARMACEUTICS;4,57;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;7,5;0,5;TRUE;63,1;2,3;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f7e8b69-fe49-476a-bf2c-b8e84d4229ba;Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy;Qian et al.;2012;10.1021/mp3002039;MOLECULAR PHARMACEUTICS;4,57;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;7,5;0,5;TRUE;85;1;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;medium without DMSO;NA;3000;200;15;NA;FALSE;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;0;0;0,5;FALSE;0,13;0,01;Absorbance (550nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;medium without DMSO;NA;3000;200;15;NA;FALSE;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;FALSE;0,44;0,02;Absorbance (550nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;medium without DMSO;NA;3000;200;15;NA;FALSE;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;5;0;0,5;FALSE;0,66;0,03;Absorbance (550nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;medium without DMSO;NA;3000;200;15;NA;FALSE;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;FALSE;0,82;0,07;Absorbance (550nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;3000;200;15;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5;FALSE;0,6;0,06;Absorbance (550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;3000;200;15;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;150;0,5;FALSE;0,55;0,05;Absorbance (550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;3000;200;15;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;200;0,5;FALSE;0,38;0,03;Absorbance (550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;3000;200;15;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;250;0,5;FALSE;0,22;0,01;Absorbance (550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;3000;200;15;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,5;FALSE;0,72;0,08;Absorbance (550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;3000;200;15;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;0;60;0,5;FALSE;0,13;0,01;Absorbance (550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;3000;200;15;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;60;0,5;FALSE;0,34;0,02;Absorbance (550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing4f9f553b-8395-4825-9e9f-78142dcb0869;Potentiation of antiglioma effect with combined temozolomide and interferon-beta;Park et al.;2006;;ONCOLOGY REPORTS;1,567;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;3000;200;15;FALSE;NA;MTT, colorimetric;not reported;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;5;60;0,5;FALSE;0,52;0,03;Absorbance (550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing51aab400-324d-4dc8-b234-6fcd1ad1d33b;IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway;Li et al.;2017;10.18632/oncotarget.15868;Oncotarget;4,795;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;0;0,5;TRUE;100;2,1;Cell viability (% of 0 M);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing51aab400-324d-4dc8-b234-6fcd1ad1d33b;IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway;Li et al.;2017;10.18632/oncotarget.15868;Oncotarget;4,795;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;100;0,5;TRUE;71,1;2,8;Cell viability (% of 0 M);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing51aab400-324d-4dc8-b234-6fcd1ad1d33b;IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway;Li et al.;2017;10.18632/oncotarget.15868;Oncotarget;4,795;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;200;0,5;TRUE;65,5;1,6;Cell viability (% of 0 M);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing51aab400-324d-4dc8-b234-6fcd1ad1d33b;IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway;Li et al.;2017;10.18632/oncotarget.15868;Oncotarget;4,795;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;25;0,5;TRUE;94;2,3;Cell viability (% of 0 M);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing51aab400-324d-4dc8-b234-6fcd1ad1d33b;IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway;Li et al.;2017;10.18632/oncotarget.15868;Oncotarget;4,795;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;400;0,5;TRUE;56,7;1,1;Cell viability (% of 0 M);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing51aab400-324d-4dc8-b234-6fcd1ad1d33b;IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway;Li et al.;2017;10.18632/oncotarget.15868;Oncotarget;4,795;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;50;0,5;TRUE;83,4;3,4;Cell viability (% of 0 M);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing545a7bc3-c653-410d-883e-f33e1f323ac0;The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells;Johannessen et al.;2012;10.1093/neuonc/nos301;Neuro-Oncology;6,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;DMSO;NA;3000;100;30;NA;FALSE;MTS, colorimetric;2;SEM;reported;TRUE;other;;NA;NA;FALSE;4;0;0,6875;TRUE;100;0;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number unclear;data missing;no data points missing545a7bc3-c653-410d-883e-f33e1f323ac0;The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells;Johannessen et al.;2012;10.1093/neuonc/nos301;Neuro-Oncology;6,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;100;30;FALSE;NA;MTS, colorimetric;2;SEM;reported;TRUE;other;;NA;NA;FALSE;4;1000;0,6875;TRUE;51,8;2,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;data missing;no data points missing545a7bc3-c653-410d-883e-f33e1f323ac0;The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells;Johannessen et al.;2012;10.1093/neuonc/nos301;Neuro-Oncology;6,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;100;30;FALSE;NA;MTS, colorimetric;2;SEM;reported;TRUE;other;;NA;NA;FALSE;4;1500;0,6875;TRUE;39,1;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;data missing;no data points missing545a7bc3-c653-410d-883e-f33e1f323ac0;The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells;Johannessen et al.;2012;10.1093/neuonc/nos301;Neuro-Oncology;6,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;100;30;FALSE;NA;MTS, colorimetric;2;SEM;reported;TRUE;other;;NA;NA;FALSE;4;2000;0,6875;TRUE;10,1;0,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;data missing;no data points missing545a7bc3-c653-410d-883e-f33e1f323ac0;The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells;Johannessen et al.;2012;10.1093/neuonc/nos301;Neuro-Oncology;6,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;100;30;FALSE;NA;MTS, colorimetric;2;SEM;reported;TRUE;other;;NA;NA;FALSE;4;500;0,6875;TRUE;64,6;2,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;data missing;no data points missing55cfea10-a7ad-4ac9-bf31-dccab2c65826;FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide;Zhang et al.;2017;10.1016/j.pharep.2017.07.003;Pharmacological Reports;2,787;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;0,5;0;0,5;TRUE;100;0,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing55cfea10-a7ad-4ac9-bf31-dccab2c65826;FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide;Zhang et al.;2017;10.1016/j.pharep.2017.07.003;Pharmacological Reports;2,787;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;0,5;100;0,5;TRUE;62,1;2,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5925c028-4c05-4622-bb34-12e135d25823;Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment;Chen et al.;2017;10.1002/jcb.26176;Journal of Cellular Biochemistry;2,959;not reported at all;not reported;Other source;not reported;DMSO;NA;10000;100;100;NA;TRUE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;0;0,5625;TRUE;100;0,5;Survival (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5925c028-4c05-4622-bb34-12e135d25823;Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment;Chen et al.;2017;10.1002/jcb.26176;Journal of Cellular Biochemistry;2,959;not reported at all;not reported;Other source;not reported;;TRUE;10000;100;100;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;10;0,5625;TRUE;86;2,1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5925c028-4c05-4622-bb34-12e135d25823;Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment;Chen et al.;2017;10.1002/jcb.26176;Journal of Cellular Biochemistry;2,959;not reported at all;not reported;Other source;not reported;;TRUE;10000;100;100;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;100;0,5625;TRUE;53;2,1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5925c028-4c05-4622-bb34-12e135d25823;Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment;Chen et al.;2017;10.1002/jcb.26176;Journal of Cellular Biochemistry;2,959;not reported at all;not reported;Other source;not reported;;TRUE;10000;100;100;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;50;0,5625;TRUE;61;2,1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5925c028-4c05-4622-bb34-12e135d25823;Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment;Chen et al.;2017;10.1002/jcb.26176;Journal of Cellular Biochemistry;2,959;not reported at all;not reported;Other source;not reported;;TRUE;10000;100;100;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;500;0,5625;TRUE;38;3,7;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5aa91e77-7ec3-40da-9680-37ce98a0ebbf;CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells;Yang et al.;2019;10.26355/eurrev_201903_17252;European Review for Medical and Pharmacological Sciences;3,024;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;not reported;NA;4000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,4375;TRUE;100;3;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing5aa91e77-7ec3-40da-9680-37ce98a0ebbf;CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells;Yang et al.;2019;10.26355/eurrev_201903_17252;European Review for Medical and Pharmacological Sciences;3,024;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;4000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;160;0,4375;TRUE;50;1,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing5aa91e77-7ec3-40da-9680-37ce98a0ebbf;CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells;Yang et al.;2019;10.26355/eurrev_201903_17252;European Review for Medical and Pharmacological Sciences;3,024;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;4000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;20;0,4375;TRUE;94,6;7,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing5aa91e77-7ec3-40da-9680-37ce98a0ebbf;CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells;Yang et al.;2019;10.26355/eurrev_201903_17252;European Review for Medical and Pharmacological Sciences;3,024;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;4000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;320;0,4375;TRUE;31,5;6,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing5aa91e77-7ec3-40da-9680-37ce98a0ebbf;CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells;Yang et al.;2019;10.26355/eurrev_201903_17252;European Review for Medical and Pharmacological Sciences;3,024;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;4000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;40;0,4375;TRUE;81,5;4,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing5aa91e77-7ec3-40da-9680-37ce98a0ebbf;CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells;Yang et al.;2019;10.26355/eurrev_201903_17252;European Review for Medical and Pharmacological Sciences;3,024;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;4000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;640;0,4375;TRUE;9,4;6,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing5aa91e77-7ec3-40da-9680-37ce98a0ebbf;CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells;Yang et al.;2019;10.26355/eurrev_201903_17252;European Review for Medical and Pharmacological Sciences;3,024;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;FALSE;4000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;80;0,4375;TRUE;72,6;5,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing5c654622-5140-4889-b524-c32a4a82c156;Anticancer activity of flavonoids isolated from Achyrocline satureioides in gliomas cell lines;De Souza et al.;2018;10.1016/j.tiv.2018.04.013;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;not reported;Sigma-Aldrich, US;high glucose & pyruvate;not reported;NA;5000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;3;SD;reported;FALSE;ATCC;;NA;70;FALSE;3;0;0,625;TRUE;95,7;7,8;Viable cells (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5c654622-5140-4889-b524-c32a4a82c156;Anticancer activity of flavonoids isolated from Achyrocline satureioides in gliomas cell lines;De Souza et al.;2018;10.1016/j.tiv.2018.04.013;Toxicology in Vitro;3,067;it is reported that there are no conflicts of interest ;not reported;Sigma-Aldrich, US;high glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;FALSE;ATCC;;NA;70;FALSE;3;200;0,625;TRUE;53,1;2,6;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;high glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;1;200;0,4375;FALSE;218;8,3;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;high glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;2;200;0,4375;FALSE;224;12,5;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;high glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;3;200;0,4375;FALSE;227;12;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;high glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;4;200;0,4375;FALSE;205,3;7,3;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;high glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;5;200;0,4375;FALSE;114;14,6;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;low glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;1;200;0,4375;FALSE;205,3;5,8;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;low glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;2;200;0,4375;FALSE;201,1;10;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;low glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;3;200;0,4375;FALSE;194,8;12,6;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;low glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;4;200;0,4375;FALSE;149,1;8,4;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5d6b5ba3-32aa-4c8e-bcbc-0bc0b4efc606;Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism cell cycle and survival;Wang et al.;2018;10.1038/s41419-017-0242-x;Cell Death and Disease;5,959;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;low glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;other;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;5;200;0,4375;FALSE;60;8,4;Cell amount;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;100;50;NA;FALSE;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;12;0;0,5625;TRUE;1,8;0,08;optical density (OD);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;100;50;NA;FALSE;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5625;TRUE;0,45;0,04;optical density (OD);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;100;50;NA;FALSE;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;0;0,5625;TRUE;0,75;0,08;optical density (OD);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;100;50;NA;FALSE;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;9;0;0,5625;TRUE;1,89;0,08;optical density (OD);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;100;50;NA;FALSE;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;12;0;0,5625;TRUE;1,8;0,07;optical density (OD);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;;TRUE;5000;100;50;FALSE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;12;10;0,5625;TRUE;1,7;0,03;optical density (OD);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;;TRUE;5000;100;50;FALSE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;12;20;0,5625;TRUE;1,4;0,07;optical density (OD);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;;TRUE;5000;100;50;FALSE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;20;0,5625;TRUE;0,52;0,02;optical density (OD);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;;TRUE;5000;100;50;FALSE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;20;0,5625;TRUE;0,61;0,1;optical density (OD);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;;TRUE;5000;100;50;FALSE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;9;20;0,5625;TRUE;0,73;0,12;optical density (OD);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;;TRUE;5000;100;50;FALSE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;12;20;0,5625;TRUE;1,39;0,06;optical density (OD);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;;TRUE;5000;100;50;FALSE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;12;40;0,5625;TRUE;0,63;0,06;optical density (OD);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing5ebff77b-4b7f-4c6e-a87c-f639a8e2386b;The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line;Josset et al.;2013;;ANTICANCER RESEARCH;1,872;it is reported that there are no conflicts of interest ;other;Thermo Fischer Scientific, US;not reported;;TRUE;5000;100;50;FALSE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;12;5;0,5625;TRUE;1,79;0,07;optical density (OD);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing62452ec0-afbf-4afd-b275-20070bbf2e65;LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway;Chen et al.;2012;10.3892/mmr.2011.674;MOLECULAR MEDICINE REPORTS ;1,17;not reported at all;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;0;0,3125;FALSE;0,4;0,08;OD 450;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing62452ec0-afbf-4afd-b275-20070bbf2e65;LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway;Chen et al.;2012;10.3892/mmr.2011.674;MOLECULAR MEDICINE REPORTS ;1,17;not reported at all;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;0;0,3125;FALSE;0,71;0,12;OD 450;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing62452ec0-afbf-4afd-b275-20070bbf2e65;LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway;Chen et al.;2012;10.3892/mmr.2011.674;MOLECULAR MEDICINE REPORTS ;1,17;not reported at all;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,3125;FALSE;0,91;0,13;OD 450;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing62452ec0-afbf-4afd-b275-20070bbf2e65;LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway;Chen et al.;2012;10.3892/mmr.2011.674;MOLECULAR MEDICINE REPORTS ;1,17;not reported at all;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;NA;0,3125;FALSE;0,38;0,05;OD 450;FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing62452ec0-afbf-4afd-b275-20070bbf2e65;LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway;Chen et al.;2012;10.3892/mmr.2011.674;MOLECULAR MEDICINE REPORTS ;1,17;not reported at all;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;NA;0,3125;FALSE;0,66;0,09;OD 450;FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing62452ec0-afbf-4afd-b275-20070bbf2e65;LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway;Chen et al.;2012;10.3892/mmr.2011.674;MOLECULAR MEDICINE REPORTS ;1,17;not reported at all;not reported;not reported;not reported;;TRUE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;NA;0,3125;FALSE;0,71;0,07;OD 450;FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing627d5a8d-c882-4fd4-aabd-79b753123d56;Autophagic flux response and glioblastoma sensitivity to radiation;Mitrakas et al.;2018;10.20892/j.issn.2095-3941.2017.0173;Cancer Biology & Medicine ;4,467;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;NA;NA;NA;NA;FALSE;Alamar Blue, colorimetric;not reported;SD;not reported;TRUE;ATCC;;NA;80;FALSE;1;0;0,4375;FALSE;98,5;1,8;Viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing627d5a8d-c882-4fd4-aabd-79b753123d56;Autophagic flux response and glioblastoma sensitivity to radiation;Mitrakas et al.;2018;10.20892/j.issn.2095-3941.2017.0173;Cancer Biology & Medicine ;4,467;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;FALSE;NA;NA;NA;FALSE;NA;Alamar Blue, colorimetric;not reported;SD;not reported;TRUE;ATCC;;NA;80;FALSE;1;10;0,4375;FALSE;67,3;8,1;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing62f09eb5-98ed-4e5c-9229-8f53ab00d321;Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo;Iwado et al.;2007;10.3892/ijo.31.5.1087;INTERNATIONAL JOURNAL OF ONCOLOGY;2,295;not reported at all;other;Thermo Fischer Scientific, US;not reported;DMSO;NA;2000;100;20;NA;FALSE;Trypan Blue exclusion, cell counting;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5625;FALSE;100;8;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing62f09eb5-98ed-4e5c-9229-8f53ab00d321;Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo;Iwado et al.;2007;10.3892/ijo.31.5.1087;INTERNATIONAL JOURNAL OF ONCOLOGY;2,295;not reported at all;other;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;1;0,5625;FALSE;74,4;3,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing62f09eb5-98ed-4e5c-9229-8f53ab00d321;Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo;Iwado et al.;2007;10.3892/ijo.31.5.1087;INTERNATIONAL JOURNAL OF ONCOLOGY;2,295;not reported at all;other;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;10;0,5625;FALSE;46,6;5,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing62f09eb5-98ed-4e5c-9229-8f53ab00d321;Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo;Iwado et al.;2007;10.3892/ijo.31.5.1087;INTERNATIONAL JOURNAL OF ONCOLOGY;2,295;not reported at all;other;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;20;0,5625;FALSE;37,4;3,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;1000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;0;0,625;TRUE;100;0;Cell growth (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;0,1;0,625;TRUE;97,6;7,5;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;1;0,625;TRUE;97,4;1;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;10;0,625;TRUE;84,8;13,9;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;100;0,625;TRUE;67,1;7,5;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;2,5;0,625;TRUE;94,2;1;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;200;0,625;TRUE;64,2;5,3;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;400;0,625;TRUE;56,2;4,6;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;5;0,625;TRUE;88,9;3,9;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;50;0,625;TRUE;77,8;9,9;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing64a785ad-4714-4ec6-b731-4d66128602f7;Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment;Ramalho et al.;2018;10.1016/j.ijpharm.2018.04.062;International Journal of Pharmaceutics;4,213;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;FALSE;1000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;TRUE;not reported;15;NA;80;FALSE;3;800;0,625;TRUE;36,8;1;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65125fda-7b0f-44e5-8f71-2505146d4f2e;EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest;Yu et al.;2017;10.1080/15384101.2017.1315492;CELL CYCLE;3,304;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;DMSO;NA;2000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5625;TRUE;100;0;Normalised cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65125fda-7b0f-44e5-8f71-2505146d4f2e;EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest;Yu et al.;2017;10.1080/15384101.2017.1315492;CELL CYCLE;3,304;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;DMSO;NA;2000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5625;TRUE;5;1;Normalised cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65125fda-7b0f-44e5-8f71-2505146d4f2e;EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest;Yu et al.;2017;10.1080/15384101.2017.1315492;CELL CYCLE;3,304;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;100;0,5625;TRUE;19,5;6;Normalised cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65125fda-7b0f-44e5-8f71-2505146d4f2e;EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest;Yu et al.;2017;10.1080/15384101.2017.1315492;CELL CYCLE;3,304;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;300;0,5625;TRUE;80;1;Normalised cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65125fda-7b0f-44e5-8f71-2505146d4f2e;EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest;Yu et al.;2017;10.1080/15384101.2017.1315492;CELL CYCLE;3,304;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;600;0,5625;TRUE;66,2;1;Normalised cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65125fda-7b0f-44e5-8f71-2505146d4f2e;EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest;Yu et al.;2017;10.1080/15384101.2017.1315492;CELL CYCLE;3,304;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;900;0,5625;TRUE;41,3;1;Normalised cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65125fda-7b0f-44e5-8f71-2505146d4f2e;EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest;Yu et al.;2017;10.1080/15384101.2017.1315492;CELL CYCLE;3,304;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;1200;0,5625;TRUE;28,1;1;Normalised cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65125fda-7b0f-44e5-8f71-2505146d4f2e;EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest;Yu et al.;2017;10.1080/15384101.2017.1315492;CELL CYCLE;3,304;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;1500;0,5625;TRUE;0;1;Normalised cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing65b98083-98fc-469f-bd94-4a2074894498;Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A;Cai et al.;2020;10.1007/s10147-020-01636-7;International Journal of Clinical Oncology;2,879;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;DMSO;NA;NA;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,5625;TRUE;101,4;2,4;relative quantity (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65b98083-98fc-469f-bd94-4a2074894498;Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A;Cai et al.;2020;10.1007/s10147-020-01636-7;International Journal of Clinical Oncology;2,879;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;DMSO;NA;NA;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5625;TRUE;126,5;126,5;relative quantity (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65b98083-98fc-469f-bd94-4a2074894498;Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A;Cai et al.;2020;10.1007/s10147-020-01636-7;International Journal of Clinical Oncology;2,879;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;DMSO;NA;NA;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;4;0;0,5625;TRUE;193;1;relative quantity (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65b98083-98fc-469f-bd94-4a2074894498;Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A;Cai et al.;2020;10.1007/s10147-020-01636-7;International Journal of Clinical Oncology;2,879;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;12800;0,5625;TRUE;62,7;4,7;relative quantity (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65b98083-98fc-469f-bd94-4a2074894498;Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A;Cai et al.;2020;10.1007/s10147-020-01636-7;International Journal of Clinical Oncology;2,879;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;12800;0,5625;TRUE;42;2,9;relative quantity (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65b98083-98fc-469f-bd94-4a2074894498;Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A;Cai et al.;2020;10.1007/s10147-020-01636-7;International Journal of Clinical Oncology;2,879;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;4;12800;0,5625;TRUE;38,2;5,2;relative quantity (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65e0c64b-fd79-4f96-b170-ef785d6aa038;Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis;Tang et al.;2019;10.1186/s40880-019-0424-2;Cancer Communications;5,627;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;DMSO;NA;4000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;ATCC;5-15;NA;NA;FALSE;2;0;0,8125;TRUE;100;1;Cell survival rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65e0c64b-fd79-4f96-b170-ef785d6aa038;Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis;Tang et al.;2019;10.1186/s40880-019-0424-2;Cancer Communications;5,627;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;5-15;NA;NA;TRUE;0;200;0,8125;TRUE;100;1,5;Cell survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65e0c64b-fd79-4f96-b170-ef785d6aa038;Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis;Tang et al.;2019;10.1186/s40880-019-0424-2;Cancer Communications;5,627;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;5-15;NA;NA;TRUE;1;200;0,8125;TRUE;83,1;3,7;Cell survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65e0c64b-fd79-4f96-b170-ef785d6aa038;Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis;Tang et al.;2019;10.1186/s40880-019-0424-2;Cancer Communications;5,627;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;5-15;NA;NA;TRUE;2;200;0,8125;TRUE;71,6;9,7;Cell survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65e0c64b-fd79-4f96-b170-ef785d6aa038;Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis;Tang et al.;2019;10.1186/s40880-019-0424-2;Cancer Communications;5,627;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;5-15;NA;NA;TRUE;3;200;0,8125;TRUE;67,8;5,1;Cell survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65e0c64b-fd79-4f96-b170-ef785d6aa038;Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis;Tang et al.;2019;10.1186/s40880-019-0424-2;Cancer Communications;5,627;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;5-15;NA;NA;TRUE;4;200;0,8125;TRUE;64,2;9,2;Cell survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65e0c64b-fd79-4f96-b170-ef785d6aa038;Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis;Tang et al.;2019;10.1186/s40880-019-0424-2;Cancer Communications;5,627;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;5-15;NA;NA;TRUE;5;200;0,8125;TRUE;61,5;7,4;Cell survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing65e0c64b-fd79-4f96-b170-ef785d6aa038;Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis;Tang et al.;2019;10.1186/s40880-019-0424-2;Cancer Communications;5,627;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;5-15;NA;NA;FALSE;0;800;0,8125;TRUE;98;2;Cell survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6609317e-1707-409d-a88f-9f7101cdbc4b;Sequential treatment of phenethyl isothiocyanate increases sensitivity of temozolomide resistant glioblastoma cells by decreasing expression of mgmt via nf-kappab pathway;Guo et al.;2019;;American Journal of Translational Research ;3,375;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;not reported;NA;5000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,4375;TRUE;100;5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6609317e-1707-409d-a88f-9f7101cdbc4b;Sequential treatment of phenethyl isothiocyanate increases sensitivity of temozolomide resistant glioblastoma cells by decreasing expression of mgmt via nf-kappab pathway;Guo et al.;2019;;American Journal of Translational Research ;3,375;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;1000;0,4375;TRUE;35;2,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6609317e-1707-409d-a88f-9f7101cdbc4b;Sequential treatment of phenethyl isothiocyanate increases sensitivity of temozolomide resistant glioblastoma cells by decreasing expression of mgmt via nf-kappab pathway;Guo et al.;2019;;American Journal of Translational Research ;3,375;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;2000;0,4375;TRUE;18,2;2,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6609317e-1707-409d-a88f-9f7101cdbc4b;Sequential treatment of phenethyl isothiocyanate increases sensitivity of temozolomide resistant glioblastoma cells by decreasing expression of mgmt via nf-kappab pathway;Guo et al.;2019;;American Journal of Translational Research ;3,375;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;3000;0,4375;TRUE;15;1,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6609317e-1707-409d-a88f-9f7101cdbc4b;Sequential treatment of phenethyl isothiocyanate increases sensitivity of temozolomide resistant glioblastoma cells by decreasing expression of mgmt via nf-kappab pathway;Guo et al.;2019;;American Journal of Translational Research ;3,375;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;4000;0,4375;TRUE;11;2,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6609317e-1707-409d-a88f-9f7101cdbc4b;Sequential treatment of phenethyl isothiocyanate increases sensitivity of temozolomide resistant glioblastoma cells by decreasing expression of mgmt via nf-kappab pathway;Guo et al.;2019;;American Journal of Translational Research ;3,375;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;5000;0,4375;TRUE;9;2,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6609317e-1707-409d-a88f-9f7101cdbc4b;Sequential treatment of phenethyl isothiocyanate increases sensitivity of temozolomide resistant glioblastoma cells by decreasing expression of mgmt via nf-kappab pathway;Guo et al.;2019;;American Journal of Translational Research ;3,375;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;6000;0,4375;TRUE;6,7;2,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;not reported;NA;2000;NA;NA;NA;FALSE;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;0;0,4375;TRUE;100;0;Survival (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;not reported;NA;2000;NA;NA;NA;FALSE;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;0;0,4375;TRUE;100;0;Survival (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;not reported;NA;2000;NA;NA;NA;FALSE;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;0;0,4375;TRUE;100;0;Survival (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;1000;0,4375;TRUE;68;4,7;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;1000;0,4375;TRUE;51,1;1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;1000;0,4375;TRUE;53,4;1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;50;0,4375;TRUE;78,3;8,8;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;50;0,4375;TRUE;79,4;1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;50;0,4375;TRUE;66,2;1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;500;0,4375;TRUE;79,3;5,9;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;500;0,4375;TRUE;68,7;1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing66cb1b02-278c-447d-a677-1ec012401dac;Temozolomide Cocrystals Exhibit Drug Sensitivity in Glioblastoma Cells;Kusuma et al.;2014;10.1007/s40010-014-0142-8;Proceedings of the National Academy of Sciences, India Section A ;0,242;not reported at all;not reported;Other source;not reported;;TRUE;2000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;6;SD;reported;FALSE;other;;NA;NA;FALSE;4;500;0,4375;TRUE;55,6;1;Survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing672fe86b-5b54-48fe-b85e-20e6e9af8a37;TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells;Tian et al.;2015;10.1016/j.bbrc.2015.05.115;Biochemical and Biophysical Research Communications;2,371;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5625;TRUE;100;7,4;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number unclear;no data missing;no data points missing672fe86b-5b54-48fe-b85e-20e6e9af8a37;TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells;Tian et al.;2015;10.1016/j.bbrc.2015.05.115;Biochemical and Biophysical Research Communications;2,371;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;10;0,5625;TRUE;73,4;3,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;no data missing;no data points missing672fe86b-5b54-48fe-b85e-20e6e9af8a37;TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells;Tian et al.;2015;10.1016/j.bbrc.2015.05.115;Biochemical and Biophysical Research Communications;2,371;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5625;TRUE;2,3;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;no data missing;no data points missing672fe86b-5b54-48fe-b85e-20e6e9af8a37;TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells;Tian et al.;2015;10.1016/j.bbrc.2015.05.115;Biochemical and Biophysical Research Communications;2,371;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;20;0,5625;TRUE;55,5;9,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;no data missing;no data points missing672fe86b-5b54-48fe-b85e-20e6e9af8a37;TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells;Tian et al.;2015;10.1016/j.bbrc.2015.05.115;Biochemical and Biophysical Research Communications;2,371;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;200;0,5625;TRUE;1;0,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;no data missing;no data points missing672fe86b-5b54-48fe-b85e-20e6e9af8a37;TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells;Tian et al.;2015;10.1016/j.bbrc.2015.05.115;Biochemical and Biophysical Research Communications;2,371;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;400;0,5625;TRUE;1;0,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;no data missing;no data points missing672fe86b-5b54-48fe-b85e-20e6e9af8a37;TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells;Tian et al.;2015;10.1016/j.bbrc.2015.05.115;Biochemical and Biophysical Research Communications;2,371;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,5625;TRUE;26,1;6,6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number unclear;no data missing;no data points missing6c82fe2d-af65-4466-aaff-0cb0287e58dd;Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line;Yi et al.;2016;10.1016/j.jns.2016.05.054;Journal of the Neurological Sciences;2,295;not reported at all;not reported;Other source;not reported;not reported;NA;5000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;0;0,5;TRUE;100;1;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6c82fe2d-af65-4466-aaff-0cb0287e58dd;Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line;Yi et al.;2016;10.1016/j.jns.2016.05.054;Journal of the Neurological Sciences;2,295;not reported at all;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;100;0,5;TRUE;58,3;1;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6c82fe2d-af65-4466-aaff-0cb0287e58dd;Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line;Yi et al.;2016;10.1016/j.jns.2016.05.054;Journal of the Neurological Sciences;2,295;not reported at all;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;1600;0,5;TRUE;24;1;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6c82fe2d-af65-4466-aaff-0cb0287e58dd;Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line;Yi et al.;2016;10.1016/j.jns.2016.05.054;Journal of the Neurological Sciences;2,295;not reported at all;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;200;0,5;TRUE;51,5;1;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6c82fe2d-af65-4466-aaff-0cb0287e58dd;Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line;Yi et al.;2016;10.1016/j.jns.2016.05.054;Journal of the Neurological Sciences;2,295;not reported at all;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;3200;0,5;TRUE;12,8;1,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6c82fe2d-af65-4466-aaff-0cb0287e58dd;Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line;Yi et al.;2016;10.1016/j.jns.2016.05.054;Journal of the Neurological Sciences;2,295;not reported at all;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;400;0,5;TRUE;53,3;1,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6c82fe2d-af65-4466-aaff-0cb0287e58dd;Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line;Yi et al.;2016;10.1016/j.jns.2016.05.054;Journal of the Neurological Sciences;2,295;not reported at all;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;50;0,5;TRUE;75;1,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6c82fe2d-af65-4466-aaff-0cb0287e58dd;Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line;Yi et al.;2016;10.1016/j.jns.2016.05.054;Journal of the Neurological Sciences;2,295;not reported at all;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;3;800;0,5;TRUE;44,3;1;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;2000;100;20;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;0;0;0,5625;TRUE;100;0;Cell viabiility (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;2000;100;20;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,5625;TRUE;100;0;Cell viabiility (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;2000;100;20;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;4;0;0,5625;TRUE;100;0;Cell viabiility (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;2000;100;20;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;0;0,5625;TRUE;100;0;Cell viabiility (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;0;10;0,5625;TRUE;100;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;10;0,5625;TRUE;69,6;19,1;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;4;10;0,5625;TRUE;40,2;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;10;0,5625;TRUE;32,5;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;0;100;0,5625;TRUE;100;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;100;0,5625;TRUE;53,1;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;4;100;0,5625;TRUE;18;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;100;0,5625;TRUE;10,3;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;0;1000;0,5625;TRUE;100;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;1000;0,5625;TRUE;42,3;6,2;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;4;1000;0,5625;TRUE;7,8;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;1000;0,5625;TRUE;2,6;1;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;0;500;0,5625;TRUE;100;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;500;0,5625;TRUE;48;2,6;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;4;500;0,5625;TRUE;10,8;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6d0d55bd-4206-4392-ba03-1f97fa9a84fe;Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide;Kanzawa et al.;2003;10.1038/sj.bjc.6601193;British Journal of Cancer;3,894;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;100;20;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;500;0,5625;TRUE;6,7;1,5;Cell viabiility (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6f3a6613-897c-4bb6-9f5a-a510bf1ec6ad;The effect of polysaccharides from Cibotium barometz on enhancing temozolomide-induced glutathione exhausted in human glioblastoma U87 cells as revealed by H-1 NMR metabolomics analysis;Shi et al.;2020;10.1016/j.ijbiomac.2020.03.243;INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES;5,162;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;DMSO;NA;5000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;0;0,6875;TRUE;95,9;2,4;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6f3a6613-897c-4bb6-9f5a-a510bf1ec6ad;The effect of polysaccharides from Cibotium barometz on enhancing temozolomide-induced glutathione exhausted in human glioblastoma U87 cells as revealed by H-1 NMR metabolomics analysis;Shi et al.;2020;10.1016/j.ijbiomac.2020.03.243;INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES;5,162;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;DMSO;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;other;;NA;NA;FALSE;3;500;0,6875;TRUE;71,4;5,1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;DMSO;NA;6000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;1;0;0,6875;TRUE;1;0,02; U87MG Viability (MTT);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;DMSO;NA;6000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;2;0;0,6875;TRUE;1;0,02; U87MG Viability (MTT);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;DMSO;NA;6000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;3;0;0,6875;TRUE;1;0,02; U87MG Viability (MTT);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;1;150;0,6875;TRUE;0,9;0,08; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;2;150;0,6875;TRUE;0,74;0,05; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;3;150;0,6875;TRUE;0,76;0,06; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;1;7,5;0,6875;TRUE;0,91;0,1; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;2;7,5;0,6875;TRUE;0,88;0,05; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;3;7,5;0,6875;TRUE;0,91;0,04; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;1;75;0,6875;TRUE;0,93;0,12; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;2;75;0,6875;TRUE;0,75;0,05; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;3;75;0,6875;TRUE;0,75;0,06; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;1;750;0,6875;TRUE;0,78;0,11; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;2;750;0,6875;TRUE;0,57;0,06; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing6ff3ffed-9aa8-4cb8-b627-58167d051aa9;Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance;Motaln et al.;2015;10.18632/oncotarget.5701;Oncotarget;5,008;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;3;750;0,6875;TRUE;0,56;0,04; U87MG Viability (MTT);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;DMSO;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5625;TRUE;1,21;0,17; cell viability (OD 550nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;0;100;0,5625;TRUE;1,25;0,12; cell viability (OD 550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,5625;TRUE;1,08;0,12; cell viability (OD 550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;100;0,5625;TRUE;0,81;0,08; cell viability (OD 550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5625;TRUE;0,49;0,07; cell viability (OD 550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5625;TRUE;1,05;0,14; cell viability (OD 550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;25;0,5625;TRUE;1,19;0,15; cell viability (OD 550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,5625;TRUE;1,09;0,12; cell viability (OD 550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing7021fc36-9b7f-4195-af23-2b08ef9541af;Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells;Wu et al.;2020;10.3390/molecules25061450;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;75;0,5625;TRUE;1,12;0,11; cell viability (OD 550nm);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing71917ccc-72d3-4c44-b454-3c0a9aadfbcb;Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas;Cheng et al.;2016;10.18632/oncotarget.8674;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;DMSO;NA;20000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,625;TRUE;100;2,2;Survival rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing71917ccc-72d3-4c44-b454-3c0a9aadfbcb;Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas;Cheng et al.;2016;10.18632/oncotarget.8674;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;20000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,625;TRUE;87,4;1,8;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing71917ccc-72d3-4c44-b454-3c0a9aadfbcb;Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas;Cheng et al.;2016;10.18632/oncotarget.8674;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;20000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;200;0,625;TRUE;80;1,8;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing71917ccc-72d3-4c44-b454-3c0a9aadfbcb;Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas;Cheng et al.;2016;10.18632/oncotarget.8674;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;20000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;300;0,625;TRUE;49,6;2,7;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;not reported;NA;10000;NA;NA;NA;FALSE;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;0;0,375;TRUE;100;6,9;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;100;0,375;TRUE;88,4;4,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;200;0,375;TRUE;85,4;4,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;0;400;0,375;TRUE;100;6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;0,5;400;0,375;TRUE;98;5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;1;400;0,375;TRUE;93;7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;400;0,375;TRUE;63;4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;400;0,375;TRUE;59;4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;400;0,375;TRUE;69,9;2,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing73124c38-128e-49cc-8c2e-a5c3363b911e;Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction;Chen et al.;2018;10.1016/j.biopha.2018.08.113;Biomedicine & Pharmacotherapy;3,743;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;6;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;800;0,375;TRUE;65;6,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7786d6d4-34ce-406f-9f90-ac4695aa0ac8;Tim-3 expression in glioma cells is associated with drug resistance;Zhang et al.;2019;10.4103/jcrt.JCRT_630_18;Journal of Cancer Research and Therapeutics;1,326;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;DMSO;NA;30000;180;166,6666667;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,625;TRUE;100;0;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7786d6d4-34ce-406f-9f90-ac4695aa0ac8;Tim-3 expression in glioma cells is associated with drug resistance;Zhang et al.;2019;10.4103/jcrt.JCRT_630_18;Journal of Cancer Research and Therapeutics;1,326;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;DMSO;NA;30000;180;166,6666667;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,625;TRUE;100;0,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7786d6d4-34ce-406f-9f90-ac4695aa0ac8;Tim-3 expression in glioma cells is associated with drug resistance;Zhang et al.;2019;10.4103/jcrt.JCRT_630_18;Journal of Cancer Research and Therapeutics;1,326;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;30000;180;166,6666667;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;1200;0,625;TRUE;47,5;2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7786d6d4-34ce-406f-9f90-ac4695aa0ac8;Tim-3 expression in glioma cells is associated with drug resistance;Zhang et al.;2019;10.4103/jcrt.JCRT_630_18;Journal of Cancer Research and Therapeutics;1,326;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;30000;180;166,6666667;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;1200;0,625;TRUE;56;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7786d6d4-34ce-406f-9f90-ac4695aa0ac8;Tim-3 expression in glioma cells is associated with drug resistance;Zhang et al.;2019;10.4103/jcrt.JCRT_630_18;Journal of Cancer Research and Therapeutics;1,326;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;30000;180;166,6666667;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;150;0,625;TRUE;96,8;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7786d6d4-34ce-406f-9f90-ac4695aa0ac8;Tim-3 expression in glioma cells is associated with drug resistance;Zhang et al.;2019;10.4103/jcrt.JCRT_630_18;Journal of Cancer Research and Therapeutics;1,326;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;30000;180;166,6666667;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;2400;0,625;TRUE;22,1;2,6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7786d6d4-34ce-406f-9f90-ac4695aa0ac8;Tim-3 expression in glioma cells is associated with drug resistance;Zhang et al.;2019;10.4103/jcrt.JCRT_630_18;Journal of Cancer Research and Therapeutics;1,326;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;30000;180;166,6666667;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;300;0,625;TRUE;83,3;2,6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7786d6d4-34ce-406f-9f90-ac4695aa0ac8;Tim-3 expression in glioma cells is associated with drug resistance;Zhang et al.;2019;10.4103/jcrt.JCRT_630_18;Journal of Cancer Research and Therapeutics;1,326;it is reported that there are no conflicts of interest ;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;30000;180;166,6666667;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;600;0,625;TRUE;71;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;2000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;0;0,5;TRUE;100;0;Cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;2000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;0;0,5;TRUE;100;0;Cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;2000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;0;0,5;TRUE;100;0;Cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;1000;0,5;TRUE;62,5;3,4;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;1000;0,5;TRUE;80,6;3,4;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;1000;0,5;TRUE;91;2,9;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;2000;0,5;TRUE;59,8;5,2;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;2000;0,5;TRUE;92;3,4;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;2000;0,5;TRUE;92;2,9;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;4000;0,5;TRUE;55,9;5,2;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;4000;0,5;TRUE;85,1;3,85;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;4000;0,5;TRUE;86,9;3,4;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;6000;0,5;TRUE;54,1;4,1;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;6000;0,5;TRUE;73,2;5,7;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;6000;0,5;TRUE;79,7;3,4;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;8000;0,5;TRUE;46;2,4;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;8000;0,5;TRUE;59,4;4,7;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7ac572dd-593a-45e8-bbdc-2908206558b2;In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme;Borhani et al.;2017;;Iranian Journal of Medical Sciences ;0,94;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;2000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;8000;0,5;TRUE;67;2,9;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing7c3ed203-d964-44e5-ac75-871625a46c55;The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study;Gokturk et al.;2018;10.5137/1019-5149.JTN.19111-16.1;Turkish Neurosurgery;0,896;not reported at all;no antibiotic;Thermo Fischer Scientific, US;not reported;not reported;NA;100000;500;200;NA;FALSE;MTT, colorimetric;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;2;0;0,375;TRUE;100;1,7;Cell number (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7c3ed203-d964-44e5-ac75-871625a46c55;The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study;Gokturk et al.;2018;10.5137/1019-5149.JTN.19111-16.1;Turkish Neurosurgery;0,896;not reported at all;no antibiotic;Thermo Fischer Scientific, US;not reported;not reported;NA;100000;500;200;NA;FALSE;MTT, colorimetric;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;4;0;0,375;TRUE;100;34,1;Cell number (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7c3ed203-d964-44e5-ac75-871625a46c55;The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study;Gokturk et al.;2018;10.5137/1019-5149.JTN.19111-16.1;Turkish Neurosurgery;0,896;not reported at all;no antibiotic;Thermo Fischer Scientific, US;not reported;not reported;NA;100000;500;200;NA;FALSE;MTT, colorimetric;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;6;0;0,375;TRUE;100;26,4;Cell number (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7c3ed203-d964-44e5-ac75-871625a46c55;The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study;Gokturk et al.;2018;10.5137/1019-5149.JTN.19111-16.1;Turkish Neurosurgery;0,896;not reported at all;no antibiotic;Thermo Fischer Scientific, US;not reported;;FALSE;100000;500;200;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;2;100;0,375;TRUE;66;5,4;Cell number (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7c3ed203-d964-44e5-ac75-871625a46c55;The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study;Gokturk et al.;2018;10.5137/1019-5149.JTN.19111-16.1;Turkish Neurosurgery;0,896;not reported at all;no antibiotic;Thermo Fischer Scientific, US;not reported;;FALSE;100000;500;200;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;4;100;0,375;TRUE;89,6;5;Cell number (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing7c3ed203-d964-44e5-ac75-871625a46c55;The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study;Gokturk et al.;2018;10.5137/1019-5149.JTN.19111-16.1;Turkish Neurosurgery;0,896;not reported at all;no antibiotic;Thermo Fischer Scientific, US;not reported;;FALSE;100000;500;200;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;not reported;;NA;NA;FALSE;6;100;0,375;TRUE;85,2;11,6;Cell number (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;DMSO;NA;2000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,625;TRUE;100;0,05;Cell viability (% of nontreated);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;DMSO;NA;2000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,625;TRUE;100;3;Cell viability (% of nontreated);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;10;0,625;TRUE;98,8;1,4;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,625;TRUE;76,9;1,4;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,625;TRUE;78;3;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;20;0,625;TRUE;89,5;0,72;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;30;0,625;TRUE;87,2;1,4;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;30;0,625;TRUE;89;3;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;300;0,625;TRUE;76,9;1,4;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;40;0,625;TRUE;82,8;0,72;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,625;TRUE;81,3;0,72;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing803a5cdf-ab6b-4f76-b286-35a14c443612;Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma;Yamada et al.;2020;10.3171/2019.12.JNS192682;J Neurosurg;3,968;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;low glucose & pyruvate;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;60;0,625;TRUE;82;3;Cell viability (% of nontreated);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;not reported;NA;NA;NA;NA;NA;FALSE;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;0;0,4375;FALSE;100;0;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;not reported;NA;NA;NA;NA;NA;FALSE;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;0;0,4375;FALSE;100;0;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;1;0,4375;FALSE;75,2;1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;10;0,4375;FALSE;100;2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;10;0,4375;FALSE;51,6;1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;100;0,4375;FALSE;88,2;3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;100;0,4375;FALSE;51,1;2,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;1000;0,4375;FALSE;1;2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;1000;0,4375;FALSE;4,8;1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;10000;0,4375;FALSE;0;1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;250;0,4375;FALSE;62,4;11;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;250;0,4375;FALSE;30,1;4,3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;2500;0,4375;FALSE;1;2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;2500;0,4375;FALSE;2,7;1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;500;0,4375;FALSE;14,3;2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;500;0,4375;FALSE;9,7;2,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;5000;0,4375;FALSE;1;2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing828c1097-b791-43fe-9bf8-3cc8b020bdd7;Polymer - Temozolomide Conjugates as Therapeutics for Treating Glioblastoma;Ward et al.;2018;10.1021/acs.molpharmaceut.8b00766;MOLECULAR PHARMACEUTICS;4,396;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;5000;0,4375;FALSE;0,5;1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing8348eaa2-160b-49e9-9a8a-cab250a0a730;Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models;Chen et al.;2011;10.1016/j.canlet.2010.11.008;Cancer Letters;4,238;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;2;SD;reported;FALSE;other;;NA;NA;FALSE;NA;0;0,5;FALSE;NA;NA;OD490(%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing8348eaa2-160b-49e9-9a8a-cab250a0a730;Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models;Chen et al.;2011;10.1016/j.canlet.2010.11.008;Cancer Letters;4,238;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;NA;NA;TRUE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;;NA;NA;FALSE;NA;1;0,5;FALSE;NA;NA;OD490(%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing86d1eac3-4f54-4d81-bd3d-673f115de939;MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy;Cardoso et al.;2019;10.1093/hmg/ddz099;Human Molecular Genetics;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;DMSO;NA;6000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;0;0,6875;TRUE;100;0,5;Cellular density (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing86d1eac3-4f54-4d81-bd3d-673f115de939;MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy;Cardoso et al.;2019;10.1093/hmg/ddz099;Human Molecular Genetics;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;DMSO;TRUE;6000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;400;0,6875;TRUE;79,5;9,05;Cellular density (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;0;0,5625;TRUE;0,51;0,03;OD value at 490nm;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,5625;TRUE;0,76;0,06;OD value at 490nm;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5625;TRUE;1,02;0,07;OD value at 490nm;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;4;0;0,5625;TRUE;1,19;0,1;OD value at 490nm;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,5625;TRUE;113;5;Cell number x1000;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;100;0,5625;TRUE;0,3;0,1;OD value at 490nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;100;0,5625;TRUE;0,32;0,1;OD value at 490nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;100;0,5625;TRUE;0,41;0,03;OD value at 490nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;4;100;0,5625;TRUE;0,52;0,06;OD value at 490nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8ac4c81e-cc63-4d82-8281-1bbd8ded58fd;Exogenous IGFBP-2 promotes proliferation invasion and chemoresistance to temozolomide in glioma cells via the integrin beta 1-ERK pathway;Han et al.;2014;10.1038/bjc.2014.435;British Journal of Cancer;4,836;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;100;0,5625;TRUE;36;8,5;Cell number x1000;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;DMSO;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;0;0,5625;TRUE;100;0;Proliferation (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;0,75;0,5625;TRUE;90;4;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;1,5;0,5625;TRUE;95;8;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;100;0,5625;TRUE;84;5;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;12,5;0,5625;TRUE;87;5;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;2,5;0,5625;TRUE;90;7;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;2,5;0,5625;TRUE;90;7;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;25;0,5625;TRUE;97;10;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;50;0,5625;TRUE;97;5;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;7,5;0,5625;TRUE;88;5;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b82677b-2876-410c-8bb2-297b92608121;Mechanisms and antitumor activity of a binary EGFR/DNA-targeting strategy overcomes resistance of glioblastoma stem cells to temozolomide;Sharifi et al.;2019;10.1158/1078-0432.CCR-19-0955;Clin Cancer Res;10,107;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;TRUE;5;75;0,5625;TRUE;100;4;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;data missing;no data points missing8b9ae2a8-c96e-483f-acb0-5fba62c8af38;beta-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathway;Liu et al.;2015;10.3892/or.2015.4050;ONCOLOGY REPORTS;2,486;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;NA;NA;5;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,5625;TRUE;100;0,5;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing8b9ae2a8-c96e-483f-acb0-5fba62c8af38;beta-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathway;Liu et al.;2015;10.3892/or.2015.4050;ONCOLOGY REPORTS;2,486;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;5;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;500;0,5625;TRUE;83,2;4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing90666892-d59e-4a37-be2b-4c003e810827;Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy;Mao et al.;2019;10.1097/CAD.0000000000000754;Anticancer Drugs;2,26;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;10000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,625;TRUE;100;0,5;Viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing90666892-d59e-4a37-be2b-4c003e810827;Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy;Mao et al.;2019;10.1097/CAD.0000000000000754;Anticancer Drugs;2,26;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;51,5063018;0,625;TRUE;90;0,5;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing90666892-d59e-4a37-be2b-4c003e810827;Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy;Mao et al.;2019;10.1097/CAD.0000000000000754;Anticancer Drugs;2,26;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;515,063018;0,625;TRUE;34,3;2,5;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing90666892-d59e-4a37-be2b-4c003e810827;Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy;Mao et al.;2019;10.1097/CAD.0000000000000754;Anticancer Drugs;2,26;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;103,0126036;0,625;TRUE;81,9;1,7;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing90666892-d59e-4a37-be2b-4c003e810827;Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy;Mao et al.;2019;10.1097/CAD.0000000000000754;Anticancer Drugs;2,26;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;206,0252072;0,625;TRUE;72,4;2,5;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing90666892-d59e-4a37-be2b-4c003e810827;Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy;Mao et al.;2019;10.1097/CAD.0000000000000754;Anticancer Drugs;2,26;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;25,7531509;0,625;TRUE;97,1;0,5;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing90666892-d59e-4a37-be2b-4c003e810827;Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy;Mao et al.;2019;10.1097/CAD.0000000000000754;Anticancer Drugs;2,26;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;309,0378108;0,625;TRUE;59,2;2,5;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing90666892-d59e-4a37-be2b-4c003e810827;Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy;Mao et al.;2019;10.1097/CAD.0000000000000754;Anticancer Drugs;2,26;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;412,0504144;0,625;TRUE;43,2;1,7;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing91eebf00-13ac-472f-9f48-cc8989f83c95;Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis;Yi et al.;2018;10.1155/2018/5238760;BioMed Research International;2,197;it is reported that there are no conflicts of interest ;no antibiotic;not reported;not reported;DMSO;NA;NA;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;not reported;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;7;0;0,375;FALSE;5,5;2,8;Trypan blue + cells (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing91eebf00-13ac-472f-9f48-cc8989f83c95;Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis;Yi et al.;2018;10.1155/2018/5238760;BioMed Research International;2,197;it is reported that there are no conflicts of interest ;no antibiotic;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;not reported;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;7;200;0,375;FALSE;75;8,8;Trypan blue + cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing932116ba-5dd7-42dc-be8b-0056f998b9c8;Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture;Burckel et al.;2014;10.3892/or.2014.3590;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Other source;not reported;DMSO;NA;5000;100;50;NA;FALSE;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;0;0,625;TRUE;99;1; Cell proliferation (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing932116ba-5dd7-42dc-be8b-0056f998b9c8;Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture;Burckel et al.;2014;10.3892/or.2014.3590;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Other source;not reported;DMSO;NA;5000;100;50;NA;FALSE;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;0;0,625;TRUE;100;1; Cell proliferation (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing932116ba-5dd7-42dc-be8b-0056f998b9c8;Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture;Burckel et al.;2014;10.3892/or.2014.3590;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Other source;not reported;;TRUE;5000;100;50;TRUE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;30;0,625;TRUE;92;7; Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing932116ba-5dd7-42dc-be8b-0056f998b9c8;Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture;Burckel et al.;2014;10.3892/or.2014.3590;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Other source;not reported;;TRUE;5000;100;50;TRUE;NA;Sulforhodamine B (SRB), colorimetric;5;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;30;0,625;TRUE;89;9; Cell proliferation (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing943294a2-8777-482b-ac29-181e35f52192;miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3;Tang et al.;2015;10.3892/mmr.2014.3101;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;not reported;NA;4000;200;20;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;0;0,4375;TRUE;0;0,5; Mean inhibition rate (%);TRUE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing943294a2-8777-482b-ac29-181e35f52192;miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3;Tang et al.;2015;10.3892/mmr.2014.3101;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;FALSE;4000;200;20;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;16000;0,4375;TRUE;70;3,2; Mean inhibition rate (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing943294a2-8777-482b-ac29-181e35f52192;miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3;Tang et al.;2015;10.3892/mmr.2014.3101;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;FALSE;4000;200;20;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;2000;0,4375;TRUE;7,1;0,5; Mean inhibition rate (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing943294a2-8777-482b-ac29-181e35f52192;miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3;Tang et al.;2015;10.3892/mmr.2014.3101;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;FALSE;4000;200;20;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;4000;0,4375;TRUE;20,2;0,9; Mean inhibition rate (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing943294a2-8777-482b-ac29-181e35f52192;miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3;Tang et al.;2015;10.3892/mmr.2014.3101;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;not reported;Hyclone Laboratories Inc, US;not reported;;FALSE;4000;200;20;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;8000;0,4375;TRUE;42;3,2; Mean inhibition rate (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing945a766c-cc8f-4479-9db0-aade32bc15b9;Inhibition of JNK Potentiates Temozolomide-induced Cytotoxicity in U87MG Glioblastoma Cells via Suppression of Akt Phosphorylation;Vo et al.;2014;;ANTICANCER RESEARCH;1,826;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;other;;NA;NA;FALSE;3;0;0,4375;FALSE;100;2,7;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing945a766c-cc8f-4479-9db0-aade32bc15b9;Inhibition of JNK Potentiates Temozolomide-induced Cytotoxicity in U87MG Glioblastoma Cells via Suppression of Akt Phosphorylation;Vo et al.;2014;;ANTICANCER RESEARCH;1,826;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;other;;NA;NA;FALSE;3;100;0,4375;FALSE;83,9;7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000000;NA;NA;NA;FALSE;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;0;0;0,625;TRUE;1;0,02;relative cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000000;NA;NA;NA;FALSE;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;0,6;0;0,625;TRUE;1,29;0,02;relative cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000000;NA;NA;NA;FALSE;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;0,9;0;0,625;TRUE;1,75;0,02;relative cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000000;NA;NA;NA;FALSE;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;1,6;0;0,625;TRUE;2,64;0,02;relative cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000000;NA;NA;NA;FALSE;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;1,9;0;0,625;TRUE;2,74;0,04;relative cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000000;NA;NA;NA;FALSE;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;2,6;0;0,625;TRUE;3,88;0,02;relative cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000000;NA;NA;NA;FALSE;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;2,9;0;0,625;TRUE;4,89;0,02;relative cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;1000000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;0;20;0,625;TRUE;1;0,02;relative cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;1000000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;0,6;20;0,625;TRUE;1,34;0,02;relative cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;1000000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;0,9;20;0,625;TRUE;1,62;0,02;relative cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;1000000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;1,6;20;0,625;TRUE;1,9;0,02;relative cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;1000000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;1,9;20;0,625;TRUE;1,81;0,02;relative cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;1000000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;2,6;20;0,625;TRUE;2,52;0,02;relative cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing97f8af00-a756-49b0-b3f5-f76858ae5dbe;Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines;Combs et al.;2008;10.1080/09553000802641151;International Journal of Radiation Biology;2,178;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;1000000;NA;NA;FALSE;NA;other;3;SD;not reported;FALSE;ATCC;15;7;NA;FALSE;2,9;20;0,625;TRUE;2,64;0,02;relative cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9a9433d1-7245-4510-9f56-8032ad295081;The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells;Xu et al.;2016;10.18632/oncotarget.7896;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;Temozolomide is the control group of the experiment;TRUE;NA;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;NA;0,4375;FALSE;86;3,9;relative growth rate of the cells (RGR) in %;FALSE;NA;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing9a9433d1-7245-4510-9f56-8032ad295081;The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells;Xu et al.;2016;10.18632/oncotarget.7896;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;Temozolomide is the control group of the experiment;TRUE;NA;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;NA;0,4375;FALSE;68,3;2,5;relative growth rate of the cells (RGR) in %;FALSE;NA;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing9a9433d1-7245-4510-9f56-8032ad295081;The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells;Xu et al.;2016;10.18632/oncotarget.7896;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;Temozolomide is the control group of the experiment;TRUE;NA;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;NA;0,4375;FALSE;64;3,9;relative growth rate of the cells (RGR) in %;FALSE;NA;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;200000;NA;NA;NA;FALSE;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;0;0,75;TRUE;100;35;U87MG viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;200000;NA;NA;NA;FALSE;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;0;0,75;TRUE;100;35;U87MG viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;200000;NA;NA;NA;FALSE;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;0;0,75;TRUE;100;35;U87MG viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;200000;NA;NA;NA;FALSE;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;0;0,75;TRUE;100;9;U87MG viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;200000;NA;NA;NA;FALSE;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;0;0,75;TRUE;100;9;U87MG viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;not reported;NA;200000;NA;NA;NA;FALSE;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;0;0,75;TRUE;100;9;U87MG viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;100;0,75;TRUE;137;4;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;100;0,75;TRUE;160;41;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;100;0,75;TRUE;75;9;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;1000;0,75;TRUE;101;23;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;1000;0,75;TRUE;86;13;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;1000;0,75;TRUE;86;12;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;125;0,75;TRUE;138;2;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;125;0,75;TRUE;151;41;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;125;0,75;TRUE;96;15;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;1250;0,75;TRUE;95;9;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;1250;0,75;TRUE;83;6;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;1250;0,75;TRUE;114;17;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;150;0,75;TRUE;131;4;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;150;0,75;TRUE;158;38;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;150;0,75;TRUE;70;7;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;1500;0,75;TRUE;73;9;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;1500;0,75;TRUE;99;6;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;1500;0,75;TRUE;112;4;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;175;0,75;TRUE;110;5;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;175;0,75;TRUE;161;45;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;175;0,75;TRUE;108;10;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;1750;0,75;TRUE;90;5;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;1750;0,75;TRUE;89;6;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;1750;0,75;TRUE;71;5;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;200;0,75;TRUE;133;6;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;200;0,75;TRUE;157;39;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;200;0,75;TRUE;98;12;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;2000;0,75;TRUE;89;5;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;2000;0,75;TRUE;99;5;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;2000;0,75;TRUE;77;5;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;25;0,75;TRUE;129;5;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;25;0,75;TRUE;139;43;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;25;0,75;TRUE;74;7;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;250;0,75;TRUE;98;8;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;250;0,75;TRUE;76;7;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;250;0,75;TRUE;75;11;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;50;0,75;TRUE;129;2;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;50;0,75;TRUE;175;14;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;50;0,75;TRUE;70;5;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;500;0,75;TRUE;80;7;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;500;0,75;TRUE;80;8;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;500;0,75;TRUE;61;11;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;75;0,75;TRUE;131;6;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;75;0,75;TRUE;178;11;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;7;75;0,75;TRUE;58;4;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;2;750;0,75;TRUE;102;10;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;3;750;0,75;TRUE;73;8;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9c39873d-c167-42cd-9fd5-7c3e92bf7ffa;Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-kappa B Signaling Pathway;Bonafe et al.;2019;10.3892/ijmm.2015.2312;Frontiers in Cellular Neuroscience;3,921;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;200000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;other;7;3,5;NA;FALSE;4;750;0,75;TRUE;83;3;U87MG viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;0;0,6875;TRUE;100;1; % of control;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;0;0,6875;TRUE;100;1; % of control;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;0;0,6875;TRUE;100;1; % of control;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;0;0,6875;TRUE;100;1; % of control;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;0;0,6875;TRUE;100;1; % of control;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;medium without DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;0;0,6875;TRUE;100;1; % of control;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;100;0,6875;TRUE;49;3; % of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;100;0,6875;TRUE;52;10; % of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;100;0,6875;TRUE;55;5; % of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;100;0,6875;TRUE;61;3; % of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;100;0,6875;TRUE;58;4; % of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9cb3f84c-86a8-42e7-9237-77684a4af6ec;Do Anti-Oxidants Vitamin D(3) Melatonin and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?;McConnell et al.;2018;10.3390/medicines5020058;Medicines (Basel);NA;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;10;NA;NA;FALSE;3;100;0,6875;TRUE;53;4; % of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9deed9c3-3f5b-4d43-89d2-22f128a03258;Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines;Liu et al.;2016;10.18632/oncotarget.9699;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;50;0,5625;FALSE;0,54;0,07;Absorbance at 450 nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9deed9c3-3f5b-4d43-89d2-22f128a03258;Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines;Liu et al.;2016;10.18632/oncotarget.9699;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;50;0,5625;FALSE;0,76;0,03;Absorbance at 450 nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9deed9c3-3f5b-4d43-89d2-22f128a03258;Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines;Liu et al.;2016;10.18632/oncotarget.9699;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;50;0,5625;FALSE;0,93;0,04;Absorbance at 450 nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9deed9c3-3f5b-4d43-89d2-22f128a03258;Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines;Liu et al.;2016;10.18632/oncotarget.9699;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;4;50;0,5625;FALSE;1,17;0,07;Absorbance at 450 nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9deed9c3-3f5b-4d43-89d2-22f128a03258;Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines;Liu et al.;2016;10.18632/oncotarget.9699;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;5;50;0,5625;FALSE;137;0,04;Absorbance at 450 nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missing9f69cc7c-6213-447a-8b4f-d0b3d080596a;The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo;K?bler et al.;2016;10.1158/1538-7445.AM2015-4458;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;DMSO;NA;NA;80;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;100;3;Vital cells (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing9f69cc7c-6213-447a-8b4f-d0b3d080596a;The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo;K?bler et al.;2016;10.1158/1538-7445.AM2015-4458;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;NA;80;NA;TRUE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;10;0,5;TRUE;96;3;Vital cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing9f69cc7c-6213-447a-8b4f-d0b3d080596a;The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo;K?bler et al.;2016;10.1158/1538-7445.AM2015-4458;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;NA;80;NA;TRUE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5;TRUE;85;7;Vital cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing9f69cc7c-6213-447a-8b4f-d0b3d080596a;The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo;K?bler et al.;2016;10.1158/1538-7445.AM2015-4458;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;NA;80;NA;TRUE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;250;0,5;TRUE;87;8;Vital cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing9f69cc7c-6213-447a-8b4f-d0b3d080596a;The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo;K?bler et al.;2016;10.1158/1538-7445.AM2015-4458;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;NA;80;NA;TRUE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,5;TRUE;89;3;Vital cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missing9f69cc7c-6213-447a-8b4f-d0b3d080596a;The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo;K?bler et al.;2016;10.1158/1538-7445.AM2015-4458;Oncotarget;5,168;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;NA;80;NA;TRUE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;500;0,5;TRUE;84;6;Vital cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;1;0;0,4375;TRUE;100;2;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;2;0;0,4375;TRUE;99,9;2,8;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;3;0;0,4375;TRUE;100;2,4;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;1;125;0,4375;TRUE;91,5;2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;2;125;0,4375;TRUE;87,5;2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;3;125;0,4375;TRUE;89,8;1,7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;1;250;0,4375;TRUE;83,6;1,7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;2;250;0,4375;TRUE;75;2,8;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;3;250;0,4375;TRUE;53,6;5,1;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;1;500;0,4375;TRUE;58,7;1,7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;2;500;0,4375;TRUE;19,8;1,2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga21e9270-0aa7-4563-9499-5a6ea72b652e;Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide;Sales et al.;2016;10.3892/ol.2016.4992;ONCOLOGY LETTERS;1,39;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;8;SEM;reported;FALSE;other;;NA;NA;FALSE;3;500;0,4375;TRUE;12,4;0,8;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;2;0;0,625;TRUE;100;7; Viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;3;0;0,625;TRUE;100;7; Viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;2;10;0,625;TRUE;97;12; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;3;10;0,625;TRUE;90;20; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;2;100;0,625;TRUE;85;14; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;3;100;0,625;TRUE;65;5; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;2;200;0,625;TRUE;78;18; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;3;200;0,625;TRUE;64;6; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;2;25;0,625;TRUE;84;7; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;3;25;0,625;TRUE;73;3; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;2;300;0,625;TRUE;76;11; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;3;300;0,625;TRUE;46;1; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;2;50;0,625;TRUE;82;3; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;3;50;0,625;TRUE;70;11; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;2;500;0,625;TRUE;62;3; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga47caeef-d61b-4b62-9781-d0a59f1bdf0c;Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells;Vengoji et al.;2019;10.1186/s13046-019-1264-2;Journal of Experimental & Clinical Cancer Research;7,068;it is reported that there are conflicts of interest ;not reported;not reported;high glucose & pyruvate;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;colleagues;15;NA;NA;FALSE;3;500;0,625;TRUE;42;5; Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga5eea77e-d942-42de-9d14-318ea8c5a802;Olanzapine inhibits proliferation migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect;Karpel-Massler et al.;2014;10.1007/s11060-014-1688-7;Journal of Neuro-Oncology;3,07;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;1500;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;0;0,5;FALSE;100;0;cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga5eea77e-d942-42de-9d14-318ea8c5a802;Olanzapine inhibits proliferation migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect;Karpel-Massler et al.;2014;10.1007/s11060-014-1688-7;Journal of Neuro-Oncology;3,07;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;1500;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;NA;0,5;FALSE;48,5;10,8;cell viability (% of control);FALSE;NA;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;not reported;NA;4000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;0;0,375;TRUE;100;0,5;Cell growth (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;10;0,375;TRUE;70,9;1,9;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;15;0,375;TRUE;68,5;2,8;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;20;0,375;TRUE;58,3;1,9;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;25;0,375;TRUE;41,4;2,3;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;30;0,375;TRUE;35,3;0,9;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;35;0,375;TRUE;31,5;1,4;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;40;0,375;TRUE;28,8;0,9;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga729a71e-a8ac-4201-98fc-13363c7932a6;Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways;Wang et al.;2011;10.3892/or.2011.1396;ONCOLOGY REPORTS;1,835;not reported at all;not reported;not reported;not reported;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;80;FALSE;2;5;0,375;TRUE;81,5;1,9;Cell growth (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinga72e4b21-2294-41cd-b386-f4c69d93481e;Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma;Adilijiang et al.;2019;10.3390/molecules24173046;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;high glucose & pyruvate;DMSO;NA;2500;NA;NA;NA;FALSE;CCK8, colorimetric;not reported;SD;not reported;FALSE;colleagues;;NA;NA;FALSE;5;0;0,5625;FALSE;100;8,9;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinga72e4b21-2294-41cd-b386-f4c69d93481e;Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma;Adilijiang et al.;2019;10.3390/molecules24173046;Molecules;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;high glucose & pyruvate;;TRUE;2500;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;not reported;FALSE;colleagues;;NA;NA;FALSE;5;97;0,5625;FALSE;63,5;5,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingad1b25e3-3281-4c87-89c2-d3894df7a33a;Fever-Range Hyperthermia vs. Hypothermia Effect on Cancer Cell Viability Proliferation and HSP90 Expression;Kalamida et al.;2015;10.1371/journal.pone.0116021;PLoS ONE;3,057;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;not reported;FALSE;other;;NA;80;FALSE;1;0;0,4375;TRUE;65,5;7,3;Cell survival (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingad1b25e3-3281-4c87-89c2-d3894df7a33a;Fever-Range Hyperthermia vs. Hypothermia Effect on Cancer Cell Viability Proliferation and HSP90 Expression;Kalamida et al.;2015;10.1371/journal.pone.0116021;PLoS ONE;3,057;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;1000;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;not reported;FALSE;other;;NA;80;FALSE;1;0;0,4375;TRUE;100;10;Cell survival (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingad1b25e3-3281-4c87-89c2-d3894df7a33a;Fever-Range Hyperthermia vs. Hypothermia Effect on Cancer Cell Viability Proliferation and HSP90 Expression;Kalamida et al.;2015;10.1371/journal.pone.0116021;PLoS ONE;3,057;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;FALSE;1000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;not reported;FALSE;other;;NA;80;FALSE;1;500;0,4375;TRUE;64,5;1,8;Cell survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingad1b25e3-3281-4c87-89c2-d3894df7a33a;Fever-Range Hyperthermia vs. Hypothermia Effect on Cancer Cell Viability Proliferation and HSP90 Expression;Kalamida et al.;2015;10.1371/journal.pone.0116021;PLoS ONE;3,057;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;FALSE;1000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;not reported;FALSE;other;;NA;80;FALSE;1;500;0,4375;TRUE;81;3;Cell survival (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingafeaea9e-1bb7-4314-881a-ea9811b22186;Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway;Wang et al.;2016;10.1093/abbs/gmw035;Acta Biochimica et Biophysica Sinica ;2,2;not reported at all;Penicillin + Streptomycin;not reported;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;0;0;0,3125;FALSE;0,25;0,02;OD (490nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingafeaea9e-1bb7-4314-881a-ea9811b22186;Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway;Wang et al.;2016;10.1093/abbs/gmw035;Acta Biochimica et Biophysica Sinica ;2,2;not reported at all;Penicillin + Streptomycin;not reported;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;0;0,3125;FALSE;0,57;0,02;OD (490nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingafeaea9e-1bb7-4314-881a-ea9811b22186;Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway;Wang et al.;2016;10.1093/abbs/gmw035;Acta Biochimica et Biophysica Sinica ;2,2;not reported at all;Penicillin + Streptomycin;not reported;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;0;0,3125;FALSE;1,53;0,06;OD (490nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingafeaea9e-1bb7-4314-881a-ea9811b22186;Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway;Wang et al.;2016;10.1093/abbs/gmw035;Acta Biochimica et Biophysica Sinica ;2,2;not reported at all;Penicillin + Streptomycin;not reported;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;0;0,3125;FALSE;2,49;0,06;OD (490nm);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingafeaea9e-1bb7-4314-881a-ea9811b22186;Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway;Wang et al.;2016;10.1093/abbs/gmw035;Acta Biochimica et Biophysica Sinica ;2,2;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;0;NA;0,3125;FALSE;0,25;0,02;OD (490nm);FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingafeaea9e-1bb7-4314-881a-ea9811b22186;Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway;Wang et al.;2016;10.1093/abbs/gmw035;Acta Biochimica et Biophysica Sinica ;2,2;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;NA;0,3125;FALSE;0,54;0,06;OD (490nm);FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingafeaea9e-1bb7-4314-881a-ea9811b22186;Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway;Wang et al.;2016;10.1093/abbs/gmw035;Acta Biochimica et Biophysica Sinica ;2,2;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;NA;0,3125;FALSE;1,13;0,08;OD (490nm);FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingafeaea9e-1bb7-4314-881a-ea9811b22186;Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway;Wang et al.;2016;10.1093/abbs/gmw035;Acta Biochimica et Biophysica Sinica ;2,2;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;NA;0,3125;FALSE;2,13;0,13;OD (490nm);FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c376e5-7358-4b31-b62c-d878e7c9ce68;N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87;Hanif et al.;2014;10.1186/s12935-014-0133-5;Cancer Cell International;2,766;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;DMSO;NA;NA;100;30;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,625;TRUE;1;1;growth inhibition (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c376e5-7358-4b31-b62c-d878e7c9ce68;N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87;Hanif et al.;2014;10.1186/s12935-014-0133-5;Cancer Cell International;2,766;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;100;30;TRUE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;25;0,625;TRUE;6,1;1;growth inhibition (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c376e5-7358-4b31-b62c-d878e7c9ce68;N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87;Hanif et al.;2014;10.1186/s12935-014-0133-5;Cancer Cell International;2,766;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;100;30;TRUE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;50;0,625;TRUE;12,8;1,2;growth inhibition (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c376e5-7358-4b31-b62c-d878e7c9ce68;N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87;Hanif et al.;2014;10.1186/s12935-014-0133-5;Cancer Cell International;2,766;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;100;30;TRUE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,625;TRUE;17,7;0,7;growth inhibition (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c376e5-7358-4b31-b62c-d878e7c9ce68;N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87;Hanif et al.;2014;10.1186/s12935-014-0133-5;Cancer Cell International;2,766;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;100;30;TRUE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;200;0,625;TRUE;27,1;0,9;growth inhibition (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c376e5-7358-4b31-b62c-d878e7c9ce68;N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87;Hanif et al.;2014;10.1186/s12935-014-0133-5;Cancer Cell International;2,766;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;100;30;TRUE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;400;0,625;TRUE;32,9;2,4;growth inhibition (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c376e5-7358-4b31-b62c-d878e7c9ce68;N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87;Hanif et al.;2014;10.1186/s12935-014-0133-5;Cancer Cell International;2,766;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;NA;100;30;TRUE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;500;0,625;TRUE;53,9;1,2;growth inhibition (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c9aa20-6bae-4900-9ebd-e009dcf7628b;Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells as well as potentiate the anticancer effect of temozolomide;Su et al.;2019;10.1016/j.phymed.2019.152840;Phytomedicine;4,268;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;medium without DMSO;NA;3000;NA;NA;NA;FALSE;Sulforhodamine B (SRB), colorimetric;2;SD;reported;FALSE;ATCC;;2;NA;FALSE;0;0;0,5625;FALSE;100;1;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c9aa20-6bae-4900-9ebd-e009dcf7628b;Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells as well as potentiate the anticancer effect of temozolomide;Su et al.;2019;10.1016/j.phymed.2019.152840;Phytomedicine;4,268;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;2;SD;reported;FALSE;ATCC;;2;NA;FALSE;0;100;0,5625;FALSE;53,7;11,3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c9aa20-6bae-4900-9ebd-e009dcf7628b;Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells as well as potentiate the anticancer effect of temozolomide;Su et al.;2019;10.1016/j.phymed.2019.152840;Phytomedicine;4,268;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;2;SD;reported;FALSE;ATCC;;2;NA;FALSE;0;200;0,5625;FALSE;50;10,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c9aa20-6bae-4900-9ebd-e009dcf7628b;Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells as well as potentiate the anticancer effect of temozolomide;Su et al.;2019;10.1016/j.phymed.2019.152840;Phytomedicine;4,268;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;2;SD;reported;FALSE;ATCC;;2;NA;FALSE;0;300;0,5625;FALSE;47,2;7,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb1c9aa20-6bae-4900-9ebd-e009dcf7628b;Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells as well as potentiate the anticancer effect of temozolomide;Su et al.;2019;10.1016/j.phymed.2019.152840;Phytomedicine;4,268;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;2;SD;reported;FALSE;ATCC;;2;NA;FALSE;0;400;0,5625;FALSE;44;7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb3599eec-a611-4133-8030-42371542a2ef;Enhancing glioblastoma cell sensitivity to chemotherapeutics: A strategy involving survivin gene silencing mediated by gemini surfactant-based complexes;Cruz et al.;2016;10.1016/j.ejpb.2016.04.014;European Journal of Pharmaceutics and Biopharmaceutics;4,159;not reported at all;Penicillin + Streptomycin;Sigma-Aldrich, US;high glucose & pyruvate;Temozolomide is the control group of the experiment;TRUE;6000;NA;NA;FALSE;FALSE;Alamar Blue, colorimetric;3;SD;reported;FALSE;colleagues;;NA;60;FALSE;3;400;0,625;TRUE;95,1;11,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingb44673a3-7db7-44ef-a555-4b6b9a049f9b;Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells;Chio et al.;2018;10.1186/s12885-018-4267-z;BMC CANCER;2,933;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;DMSO;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,5;TRUE;1,31;0,12;Cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingb44673a3-7db7-44ef-a555-4b6b9a049f9b;Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells;Chio et al.;2018;10.1186/s12885-018-4267-z;BMC CANCER;2,933;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;DMSO;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;1,29;0,14;Cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingb44673a3-7db7-44ef-a555-4b6b9a049f9b;Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells;Chio et al.;2018;10.1186/s12885-018-4267-z;BMC CANCER;2,933;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;100;0,5;TRUE;0,97;0,1;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingb44673a3-7db7-44ef-a555-4b6b9a049f9b;Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells;Chio et al.;2018;10.1186/s12885-018-4267-z;BMC CANCER;2,933;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5;TRUE;0,73;0,11;Cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingb4dae4ce-99ef-413e-accc-8f6c58fea931;MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma;Liu et al.;2017;10.18632/oncotarget.21309;Oncotarget;4,795;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5625;TRUE;100;1;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingb4dae4ce-99ef-413e-accc-8f6c58fea931;MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma;Liu et al.;2017;10.18632/oncotarget.21309;Oncotarget;4,795;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;10;0,5625;TRUE;91,3;2,1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingb4dae4ce-99ef-413e-accc-8f6c58fea931;MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma;Liu et al.;2017;10.18632/oncotarget.21309;Oncotarget;4,795;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5625;TRUE;57,2;2,6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingb4dae4ce-99ef-413e-accc-8f6c58fea931;MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma;Liu et al.;2017;10.18632/oncotarget.21309;Oncotarget;4,795;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;25;0,5625;TRUE;86,1;2,1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingb4dae4ce-99ef-413e-accc-8f6c58fea931;MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma;Liu et al.;2017;10.18632/oncotarget.21309;Oncotarget;4,795;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,5625;TRUE;69,3;2,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;1;0;0,6875;TRUE;100;0,5;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;2;0;0,6875;TRUE;100;0,5;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;3;0;0,6875;TRUE;100;0,5;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;1;160;0,6875;TRUE;87;2,7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;2;160;0,6875;TRUE;75,2;6,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;3;160;0,6875;TRUE;49,6;0,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;1;240;0,6875;TRUE;72,6;2,2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;2;240;0,6875;TRUE;53,8;4,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;3;240;0,6875;TRUE;40,3;4,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;1;320;0,6875;TRUE;70,9;0,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;2;320;0,6875;TRUE;49,4;4,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;3;320;0,6875;TRUE;37,1;2,7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;1;40;0,6875;TRUE;98;0,5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;2;40;0,6875;TRUE;91,9;2,7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;3;40;0,6875;TRUE;69,2;6;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;1;80;0,6875;TRUE;95;2,2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;2;80;0,6875;TRUE;84,4;2,7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingb5a1af17-52df-4ecc-997c-68d8919c2d83;Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway;Liu et al.;2014;10.1158/1535-7163.MCT-14-0634;Molecular Cancer Therapeutics;5,683;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);10;NA;NA;FALSE;3;80;0,6875;TRUE;53,3;2,2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingbb056e51-f833-4bbc-a8f1-eecfe62bf9c9;ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells;Nadkarni et al.;2012;10.1007/s11060-012-0979-0;Journal of Neuro-Oncology;3,115;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;high glucose & pyruvate;DMSO;NA;500;NA;NA;NA;FALSE;other;2;SEM;reported;FALSE;not reported;8;NA;NA;FALSE;6;0;0,5625;TRUE;100;1;Absorbance (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingbb056e51-f833-4bbc-a8f1-eecfe62bf9c9;ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells;Nadkarni et al.;2012;10.1007/s11060-012-0979-0;Journal of Neuro-Oncology;3,115;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;high glucose & pyruvate;DMSO;FALSE;500;NA;NA;FALSE;NA;other;2;SEM;reported;FALSE;not reported;8;NA;NA;FALSE;6;10;0,5625;TRUE;80,8;3,2;Absorbance (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingbb056e51-f833-4bbc-a8f1-eecfe62bf9c9;ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells;Nadkarni et al.;2012;10.1007/s11060-012-0979-0;Journal of Neuro-Oncology;3,115;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;high glucose & pyruvate;DMSO;FALSE;500;NA;NA;FALSE;NA;other;2;SEM;reported;FALSE;not reported;8;NA;NA;FALSE;6;100;0,5625;TRUE;30,1;2,7;Absorbance (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingbb056e51-f833-4bbc-a8f1-eecfe62bf9c9;ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells;Nadkarni et al.;2012;10.1007/s11060-012-0979-0;Journal of Neuro-Oncology;3,115;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;high glucose & pyruvate;DMSO;FALSE;500;NA;NA;FALSE;NA;other;2;SEM;reported;FALSE;not reported;8;NA;NA;FALSE;6;30;0,5625;TRUE;52,4;1,5;Absorbance (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingbb056e51-f833-4bbc-a8f1-eecfe62bf9c9;ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells;Nadkarni et al.;2012;10.1007/s11060-012-0979-0;Journal of Neuro-Oncology;3,115;it is reported that there are conflicts of interest ;Penicillin + Streptomycin;not reported;high glucose & pyruvate;DMSO;FALSE;500;NA;NA;FALSE;NA;other;2;SEM;reported;FALSE;not reported;8;NA;NA;FALSE;6;300;0,5625;TRUE;19,1;1;Absorbance (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingbbcbd017-25aa-424b-9363-4c7ef5a52d7b;The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines;Elhag et al.;2015;;Anticancer Research;1,895;not reported at all;Penicillin + Streptomycin;not reported;not reported;DMSO;NA;50000;100;500;NA;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;70;FALSE;2;0;0,625;TRUE;100;2;Viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missingbbcbd017-25aa-424b-9363-4c7ef5a52d7b;The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines;Elhag et al.;2015;;Anticancer Research;1,895;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;50000;100;500;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;70;FALSE;2;25;0,625;TRUE;87;2;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missingbbcbd017-25aa-424b-9363-4c7ef5a52d7b;The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines;Elhag et al.;2015;;Anticancer Research;1,895;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;50000;100;500;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;70;FALSE;2;50;0,625;TRUE;68;4;Viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missingbf81dcce-7a42-4509-af83-30521c164d77;MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity;Shi et al.;2010;10.1016/j.brainres.2010.07.009;Brain Research;2,623;not reported at all;not reported;not reported;not reported;not reported;NA;NA;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;not reported;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;2,5;NA;FALSE;0;0;0,3125;FALSE;102;2,8;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingbf81dcce-7a42-4509-af83-30521c164d77;MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity;Shi et al.;2010;10.1016/j.brainres.2010.07.009;Brain Research;2,623;not reported at all;not reported;not reported;not reported;;FALSE;NA;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;not reported;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;2,5;NA;FALSE;0;100;0,3125;FALSE;53,3;10;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingc1683855-0076-441f-99c7-0cdc8e3873f1;The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells;Lee et al.;2015;10.1016/j.canlet.2015.02.012;Cancer Letters;5,992;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;medium without DMSO;NA;1000;NA;NA;NA;FALSE;MTS, colorimetric;2;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;100;4,3;Proliferation (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingc1683855-0076-441f-99c7-0cdc8e3873f1;The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells;Lee et al.;2015;10.1016/j.canlet.2015.02.012;Cancer Letters;5,992;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;medium without DMSO;NA;1000;NA;NA;NA;FALSE;MTS, colorimetric;2;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;2,29;0,03;Proliferation (A 490);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingc1683855-0076-441f-99c7-0cdc8e3873f1;The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells;Lee et al.;2015;10.1016/j.canlet.2015.02.012;Cancer Letters;5,992;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;medium without DMSO;NA;1000;NA;NA;NA;FALSE;MTS, colorimetric;2;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;1,78;0,06;Proliferation (A 490);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingc1683855-0076-441f-99c7-0cdc8e3873f1;The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells;Lee et al.;2015;10.1016/j.canlet.2015.02.012;Cancer Letters;5,992;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTS, colorimetric;2;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5;TRUE;38,3;2,3;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingc1683855-0076-441f-99c7-0cdc8e3873f1;The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells;Lee et al.;2015;10.1016/j.canlet.2015.02.012;Cancer Letters;5,992;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTS, colorimetric;2;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;200;0,5;TRUE;31,4;2,3;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingc1683855-0076-441f-99c7-0cdc8e3873f1;The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells;Lee et al.;2015;10.1016/j.canlet.2015.02.012;Cancer Letters;5,992;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTS, colorimetric;2;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,5;TRUE;80,5;1,5;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingc1683855-0076-441f-99c7-0cdc8e3873f1;The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells;Lee et al.;2015;10.1016/j.canlet.2015.02.012;Cancer Letters;5,992;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTS, colorimetric;2;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,5;TRUE;1,81;0,03;Proliferation (A 490);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingc1683855-0076-441f-99c7-0cdc8e3873f1;The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells;Lee et al.;2015;10.1016/j.canlet.2015.02.012;Cancer Letters;5,992;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;1000;NA;NA;FALSE;NA;MTS, colorimetric;2;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,5;TRUE;1,32;0,04;Proliferation (A 490);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;data missing;no data points missingc2320d09-2c4f-413e-b3e3-a2f5a896a357;Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth;QI et al.;2013;10.1038/aps.2013.40;Acta Pharmacologica Sinica;2,496;not reported at all;Penicillin + Streptomycin;not reported;high glucose & pyruvate;DMSO;NA;4000;NA;NA;NA;FALSE;MTT, colorimetric;2;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;0;0,5;TRUE;100;3,7;Cell proliferation (% of vehicle);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingc2320d09-2c4f-413e-b3e3-a2f5a896a357;Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth;QI et al.;2013;10.1038/aps.2013.40;Acta Pharmacologica Sinica;2,496;not reported at all;Penicillin + Streptomycin;not reported;high glucose & pyruvate;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;10;0,5;TRUE;88,6;4,6;Cell proliferation (% of vehicle);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingc2320d09-2c4f-413e-b3e3-a2f5a896a357;Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth;QI et al.;2013;10.1038/aps.2013.40;Acta Pharmacologica Sinica;2,496;not reported at all;Penicillin + Streptomycin;not reported;high glucose & pyruvate;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;100;0,5;TRUE;46,2;4;Cell proliferation (% of vehicle);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingc2320d09-2c4f-413e-b3e3-a2f5a896a357;Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth;QI et al.;2013;10.1038/aps.2013.40;Acta Pharmacologica Sinica;2,496;not reported at all;Penicillin + Streptomycin;not reported;high glucose & pyruvate;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;20;0,5;TRUE;76,6;3,7;Cell proliferation (% of vehicle);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingc2320d09-2c4f-413e-b3e3-a2f5a896a357;Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth;QI et al.;2013;10.1038/aps.2013.40;Acta Pharmacologica Sinica;2,496;not reported at all;Penicillin + Streptomycin;not reported;high glucose & pyruvate;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;5;0,5;TRUE;96;4,6;Cell proliferation (% of vehicle);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingc2320d09-2c4f-413e-b3e3-a2f5a896a357;Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth;QI et al.;2013;10.1038/aps.2013.40;Acta Pharmacologica Sinica;2,496;not reported at all;Penicillin + Streptomycin;not reported;high glucose & pyruvate;;TRUE;4000;NA;NA;FALSE;NA;MTT, colorimetric;2;SD;reported;FALSE;not reported;;NA;NA;FALSE;3;50;0,5;TRUE;56,3;5,5;Cell proliferation (% of vehicle);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;8000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5625;TRUE;100;1;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;8000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;100;0,5625;TRUE;60,6;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;8000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;1000;0,5625;TRUE;32,9;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;8000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;1200;0,5625;TRUE;27,2;3,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;8000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;200;0,5625;TRUE;56,8;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;8000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;2000;0,5625;TRUE;24,9;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;8000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;400;0,5625;TRUE;45,6;3,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;8000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;50;0,5625;TRUE;75,8;2,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc23a74cd-5366-43a3-9328-b684438a02d2;MiR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway;Li et al.;2018;10.1186/s13045-018-0618-0;Journal of Hematology & Oncology;8,731;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;8000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;800;0,5625;TRUE;31;1,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc70fc84a-003c-492c-85d3-bafa0fdbf122;Bufothionine Promotes Apoptosis via Triggering ER Stress and Synergizes with Temozolomide in Glioblastoma Multiforme Cells;Sun et al.;2019;10.1002/ar.24194;THE ANATOMICAL RECORD;1,634;not reported at all;no antibiotic;Hyclone Laboratories Inc, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,4375;TRUE;100;0,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc70fc84a-003c-492c-85d3-bafa0fdbf122;Bufothionine Promotes Apoptosis via Triggering ER Stress and Synergizes with Temozolomide in Glioblastoma Multiforme Cells;Sun et al.;2019;10.1002/ar.24194;THE ANATOMICAL RECORD;1,634;not reported at all;no antibiotic;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;100;0,4375;TRUE;52,7;9,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc70fc84a-003c-492c-85d3-bafa0fdbf122;Bufothionine Promotes Apoptosis via Triggering ER Stress and Synergizes with Temozolomide in Glioblastoma Multiforme Cells;Sun et al.;2019;10.1002/ar.24194;THE ANATOMICAL RECORD;1,634;not reported at all;no antibiotic;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;200;0,4375;TRUE;35,2;6,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc70fc84a-003c-492c-85d3-bafa0fdbf122;Bufothionine Promotes Apoptosis via Triggering ER Stress and Synergizes with Temozolomide in Glioblastoma Multiforme Cells;Sun et al.;2019;10.1002/ar.24194;THE ANATOMICAL RECORD;1,634;not reported at all;no antibiotic;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;50;0,4375;TRUE;82,6;10,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc92f3d8e-63b4-4fa6-a009-a4cc5bdd71fc;YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line;Akiyama et al.;2014;10.3892/or.2014.3195;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;12000;NA;NA;NA;FALSE;WST-1 assay, colorimetric;not reported;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;4;0;0,375;FALSE;1,3;0,1;OD at 450nm;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc92f3d8e-63b4-4fa6-a009-a4cc5bdd71fc;YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line;Akiyama et al.;2014;10.3892/or.2014.3195;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;12000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;not reported;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;4;1000;0,375;FALSE;0,29;0,05;OD at 450nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc92f3d8e-63b4-4fa6-a009-a4cc5bdd71fc;YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line;Akiyama et al.;2014;10.3892/or.2014.3195;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;12000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;not reported;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;4;25;0,375;FALSE;1,08;0,09;OD at 450nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc92f3d8e-63b4-4fa6-a009-a4cc5bdd71fc;YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line;Akiyama et al.;2014;10.3892/or.2014.3195;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;12000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;not reported;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;4;250;0,375;FALSE;0,58;0,06;OD at 450nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc92f3d8e-63b4-4fa6-a009-a4cc5bdd71fc;YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line;Akiyama et al.;2014;10.3892/or.2014.3195;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;12000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;not reported;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;4;50;0,375;FALSE;0,8;0,09;OD at 450nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingc92f3d8e-63b4-4fa6-a009-a4cc5bdd71fc;YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line;Akiyama et al.;2014;10.3892/or.2014.3195;ONCOLOGY REPORTS;2,301;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;12000;NA;NA;FALSE;NA;WST-1 assay, colorimetric;not reported;SD;not reported;FALSE;ATCC;;NA;NA;FALSE;4;500;0,375;FALSE;0,4;0,11;OD at 450nm;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;not reported;NA;NA;NA;NA;NA;FALSE;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,4375;TRUE;100;2;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;1000;0,4375;TRUE;14,5;2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;128;0,4375;TRUE;42,4;4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;16;0,4375;TRUE;81,3;11;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;2000;0,4375;TRUE;13;3;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;256;0,4375;TRUE;31,3;3;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;3;0,4375;TRUE;94,2;2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;32;0,4375;TRUE;67,4;7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;500;0,4375;TRUE;23,1;2;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;64;0,4375;TRUE;53,4;5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcc7b32c6-5485-4ed8-90cf-562706fa6955;Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action;Punganuru et al.;2020;10.3390/cells9071592;Cells ;4,366;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;TRUE;NA;NA;NA;FALSE;NA;other;4;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;8;0,4375;TRUE;89,9;4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcd442914-dc00-4830-a343-658924849695;Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line;Franco et al.;2018;10.3390/molecules23051129;Molecules;3,06;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;DMSO;NA;NA;NA;NA;NA;FALSE;other;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;3;0;0,625;TRUE;100;1;viability (% of vehicle);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcd442914-dc00-4830-a343-658924849695;Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line;Franco et al.;2018;10.3390/molecules23051129;Molecules;3,06;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;3;800;0,625;TRUE;47,4;2,1;viability (% of vehicle);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingcd9cc8b6-ff29-4acd-a1d6-4b1c4764daad;The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior;Zhang et al.;2012;10.3390/ijms13011109;International Journal of Molecular Sciences;2,464;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;6000;200;30;TRUE;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;50;0,5625;TRUE;99;1,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingcd9cc8b6-ff29-4acd-a1d6-4b1c4764daad;The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior;Zhang et al.;2012;10.3390/ijms13011109;International Journal of Molecular Sciences;2,464;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;6000;200;30;TRUE;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;50;0,5625;TRUE;92;1,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingcd9cc8b6-ff29-4acd-a1d6-4b1c4764daad;The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior;Zhang et al.;2012;10.3390/ijms13011109;International Journal of Molecular Sciences;2,464;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;6000;200;30;TRUE;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;50;0,5625;TRUE;83;1,8;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingcd9cc8b6-ff29-4acd-a1d6-4b1c4764daad;The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior;Zhang et al.;2012;10.3390/ijms13011109;International Journal of Molecular Sciences;2,464;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;6000;200;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;50;0,5625;TRUE;99;2,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingcd9cc8b6-ff29-4acd-a1d6-4b1c4764daad;The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior;Zhang et al.;2012;10.3390/ijms13011109;International Journal of Molecular Sciences;2,464;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;6000;200;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;50;0,5625;TRUE;88,7;1,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingcd9cc8b6-ff29-4acd-a1d6-4b1c4764daad;The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior;Zhang et al.;2012;10.3390/ijms13011109;International Journal of Molecular Sciences;2,464;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;6000;200;30;TRUE;FALSE;MTT, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;50;0,5625;TRUE;78,5;2,4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;NA;NA;NA;NA;NA;FALSE;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;0;0;0,6875;TRUE;0,31;0;OD490;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;NA;NA;NA;NA;NA;FALSE;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;0;0,6875;TRUE;0,4;0,01;OD490;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;NA;NA;NA;NA;NA;FALSE;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;0;0,6875;TRUE;0,49;0,01;OD490;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;NA;NA;NA;NA;NA;FALSE;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;0;0,6875;TRUE;0,65;0,02;OD490;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;0;1;0,6875;TRUE;0,3;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;1;0,6875;TRUE;0,4;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;1;0,6875;TRUE;0,49;0,02;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;1;0,6875;TRUE;0,62;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;0;10;0,6875;TRUE;0,31;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;10;0,6875;TRUE;0,38;0,02;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;10;0,6875;TRUE;0,47;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;10;0,6875;TRUE;0,59;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;0;20;0,6875;TRUE;0,3;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;20;0,6875;TRUE;0,37;0,02;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;20;0,6875;TRUE;0,46;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;20;0,6875;TRUE;0,58;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;0;5;0,6875;TRUE;0,3;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;5;0,6875;TRUE;0,39;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;2;5;0,6875;TRUE;0,47;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcea51952-de58-4120-8cc1-dc6a2a441661;Study on therapeutic action and mechanism of TMZ Combined with RITA against glioblastoma;Wu et al.;2018;10.1159/000495923;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY ;5,11;it is reported that there are no conflicts of interest ;other;Hyclone Laboratories Inc, US;high glucose & pyruvate;;TRUE;NA;NA;NA;FALSE;NA;MTS, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;3;5;0,6875;TRUE;0,61;0,01;OD490;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcfce2e42-f3af-4fbf-b146-829d6c4ddb9e;FTO inhibition enhances the anti-tumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma;Xiao et al.;2020;10.1158/0008-5472.CAN-20-0132;Cancer Research;9,727;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;TRUE;ATCC;All cell lined used have been passaged less than 3 months, at which point a previously frozen vial was thawed.;NA;NA;TRUE;0;200;0,5625;FALSE;0,93;0,05;Relative absorbance;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcfce2e42-f3af-4fbf-b146-829d6c4ddb9e;FTO inhibition enhances the anti-tumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma;Xiao et al.;2020;10.1158/0008-5472.CAN-20-0132;Cancer Research;9,727;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;TRUE;ATCC;All cell lined used have been passaged less than 3 months, at which point a previously frozen vial was thawed.;NA;NA;TRUE;1;200;0,5625;FALSE;0,86;0,04;Relative absorbance;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcfce2e42-f3af-4fbf-b146-829d6c4ddb9e;FTO inhibition enhances the anti-tumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma;Xiao et al.;2020;10.1158/0008-5472.CAN-20-0132;Cancer Research;9,727;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;TRUE;ATCC;All cell lined used have been passaged less than 3 months, at which point a previously frozen vial was thawed.;NA;NA;TRUE;2;200;0,5625;FALSE;0,82;0,03;Relative absorbance;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcfce2e42-f3af-4fbf-b146-829d6c4ddb9e;FTO inhibition enhances the anti-tumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma;Xiao et al.;2020;10.1158/0008-5472.CAN-20-0132;Cancer Research;9,727;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;TRUE;ATCC;All cell lined used have been passaged less than 3 months, at which point a previously frozen vial was thawed.;NA;NA;TRUE;3;200;0,5625;FALSE;0,78;0,03;Relative absorbance;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcfce2e42-f3af-4fbf-b146-829d6c4ddb9e;FTO inhibition enhances the anti-tumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma;Xiao et al.;2020;10.1158/0008-5472.CAN-20-0132;Cancer Research;9,727;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;TRUE;ATCC;All cell lined used have been passaged less than 3 months, at which point a previously frozen vial was thawed.;NA;NA;TRUE;4;200;0,5625;FALSE;0,53;0,04;Relative absorbance;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingcfce2e42-f3af-4fbf-b146-829d6c4ddb9e;FTO inhibition enhances the anti-tumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma;Xiao et al.;2020;10.1158/0008-5472.CAN-20-0132;Cancer Research;9,727;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;NA;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;not reported;TRUE;ATCC;All cell lined used have been passaged less than 3 months, at which point a previously frozen vial was thawed.;NA;NA;TRUE;5;200;0,5625;FALSE;0,43;0,05;Relative absorbance;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd033365b-a968-4559-ab12-2ea17e5908e1;The Pan-Bcl-2 Inhibitor (-)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma;Voss et al.;2010;10.1158/1541-7786.MCR-09-0562;MOLECULAR CANCER RESEARCH;4,373;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;high glucose & pyruvate;not reported;NA;2000;NA;NA;NA;FALSE;MTT, colorimetric;16;SEM;reported;FALSE;not reported;;NA;NA;FALSE;4;0;0,5625;TRUE;38,3;0,01;Absorbance;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd033365b-a968-4559-ab12-2ea17e5908e1;The Pan-Bcl-2 Inhibitor (-)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma;Voss et al.;2010;10.1158/1541-7786.MCR-09-0562;MOLECULAR CANCER RESEARCH;4,373;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;high glucose & pyruvate;;TRUE;2000;NA;NA;FALSE;NA;MTT, colorimetric;16;SEM;reported;FALSE;not reported;;NA;NA;FALSE;4;100;0,5625;TRUE;24,7;0,01;Absorbance;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd0b94a30-f0a6-4b12-9256-a6de9c8ca597;MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma;Xu et al.;2020;10.26355/eurrev_202002_20370;European Review for Medical and Pharmacological Sciences ;3,024;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,5;TRUE;100;1,5;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd0b94a30-f0a6-4b12-9256-a6de9c8ca597;MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma;Xu et al.;2020;10.26355/eurrev_202002_20370;European Review for Medical and Pharmacological Sciences ;3,024;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;100;0,5;TRUE;53,1;7,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd0b94a30-f0a6-4b12-9256-a6de9c8ca597;MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma;Xu et al.;2020;10.26355/eurrev_202002_20370;European Review for Medical and Pharmacological Sciences ;3,024;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;50;0,5;TRUE;71;8,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd2d89a0d-36f5-4b24-a5bb-47d2639d31d4;BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction;Yao et al.;2019;10.1038/s41417-018-0068-4;Cancer Gene Therapy;4,534;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;not reported;NA;5000;NA;NA;NA;FALSE;CCK8, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;TRUE;3;0;0,375;FALSE;100;2,1;Relative cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd2d89a0d-36f5-4b24-a5bb-47d2639d31d4;BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction;Yao et al.;2019;10.1038/s41417-018-0068-4;Cancer Gene Therapy;4,534;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;FALSE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;TRUE;3;100;0,375;FALSE;73;3,1;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd2d89a0d-36f5-4b24-a5bb-47d2639d31d4;BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction;Yao et al.;2019;10.1038/s41417-018-0068-4;Cancer Gene Therapy;4,534;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;FALSE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;TRUE;3;200;0,375;FALSE;55,6;1,6;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd2d89a0d-36f5-4b24-a5bb-47d2639d31d4;BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction;Yao et al.;2019;10.1038/s41417-018-0068-4;Cancer Gene Therapy;4,534;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;FALSE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;TRUE;3;25;0,375;FALSE;94,4;3,2;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd2d89a0d-36f5-4b24-a5bb-47d2639d31d4;BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction;Yao et al.;2019;10.1038/s41417-018-0068-4;Cancer Gene Therapy;4,534;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;FALSE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;TRUE;3;400;0,375;FALSE;32,4;1;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd2d89a0d-36f5-4b24-a5bb-47d2639d31d4;BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction;Yao et al.;2019;10.1038/s41417-018-0068-4;Cancer Gene Therapy;4,534;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;FALSE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;TRUE;3;50;0,375;FALSE;82,4;4,2;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd306050e-218a-4db8-bbc0-3a174f59beae;Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells;Takeuchi et al.;2004;10.3892/ijo.25.1.57;INTERNATIONAL JOURNAL OF ONCOLOGY;3,056;not reported at all;Penicillin + Streptomycin;not reported;not reported;not reported;NA;5000;100;50;NA;FALSE;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;100;0;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd306050e-218a-4db8-bbc0-3a174f59beae;Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells;Takeuchi et al.;2004;10.3892/ijo.25.1.57;INTERNATIONAL JOURNAL OF ONCOLOGY;3,056;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;100;50;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;1;0,5;TRUE;88,7;3,6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd306050e-218a-4db8-bbc0-3a174f59beae;Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells;Takeuchi et al.;2004;10.3892/ijo.25.1.57;INTERNATIONAL JOURNAL OF ONCOLOGY;3,056;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;100;50;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;10;0,5;TRUE;51,3;3,1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd306050e-218a-4db8-bbc0-3a174f59beae;Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells;Takeuchi et al.;2004;10.3892/ijo.25.1.57;INTERNATIONAL JOURNAL OF ONCOLOGY;3,056;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;100;50;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5;TRUE;20,1;3,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd306050e-218a-4db8-bbc0-3a174f59beae;Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells;Takeuchi et al.;2004;10.3892/ijo.25.1.57;INTERNATIONAL JOURNAL OF ONCOLOGY;3,056;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;100;50;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;2,5;0,5;TRUE;87,4;4,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd306050e-218a-4db8-bbc0-3a174f59beae;Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells;Takeuchi et al.;2004;10.3892/ijo.25.1.57;INTERNATIONAL JOURNAL OF ONCOLOGY;3,056;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;100;50;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;25;0,5;TRUE;27,6;3,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd306050e-218a-4db8-bbc0-3a174f59beae;Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells;Takeuchi et al.;2004;10.3892/ijo.25.1.57;INTERNATIONAL JOURNAL OF ONCOLOGY;3,056;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;100;50;FALSE;NA;Trypan Blue exclusion, cell counting;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;250;0,5;TRUE;18,4;1,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd35a2ba9-5cdd-4314-aa6c-b2e3b01d3f6b;Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy;Golden et al.;2014;10.3171/2014.9.FOCUS14504;Neurosurgical focus;2,546;not reported at all;Penicillin + Streptomycin;not reported;not reported;not reported;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;1;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,375;TRUE;100;12,3;Viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd35a2ba9-5cdd-4314-aa6c-b2e3b01d3f6b;Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy;Golden et al.;2014;10.3171/2014.9.FOCUS14504;Neurosurgical focus;2,546;not reported at all;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;1;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;60;0,375;TRUE;60,3;6,2;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd44f6fda-2053-49b0-a99e-b15975841e14;Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma;Fan et al.;2014;;International Journal of Clinical and Experimental Pathology ;1,891;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;50000;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;0;0,3125;FALSE;100;6,9;Relative cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd44f6fda-2053-49b0-a99e-b15975841e14;Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma;Fan et al.;2014;;International Journal of Clinical and Experimental Pathology ;1,891;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;50000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;100;0,3125;FALSE;32,2;5,9;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd44f6fda-2053-49b0-a99e-b15975841e14;Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma;Fan et al.;2014;;International Journal of Clinical and Experimental Pathology ;1,891;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;50000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;200;0,3125;FALSE;13,2;4,4;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd44f6fda-2053-49b0-a99e-b15975841e14;Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma;Fan et al.;2014;;International Journal of Clinical and Experimental Pathology ;1,891;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;50000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;25;0,3125;FALSE;82;9,3;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd44f6fda-2053-49b0-a99e-b15975841e14;Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma;Fan et al.;2014;;International Journal of Clinical and Experimental Pathology ;1,891;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;50000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;not reported;;NA;NA;FALSE;2;50;0,3125;FALSE;57,1;6,4;Relative cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd4ac184c-157a-48f5-a6dc-4b063a5e39e4;In vitro and in vivo effect of human lactoferrin on glioblastoma growth;Arcella et al.;2015;10.3171/2014.12.JNS14512;JOURNAL OF NEUROSURGERY;3,443;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;NA;NA;NA;FALSE;other;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,4375;TRUE;13500;1000;Cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd4ac184c-157a-48f5-a6dc-4b063a5e39e4;In vitro and in vivo effect of human lactoferrin on glioblastoma growth;Arcella et al.;2015;10.3171/2014.12.JNS14512;JOURNAL OF NEUROSURGERY;3,443;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;NA;NA;NA;FALSE;other;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,4375;TRUE;28500;1000;Cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd4ac184c-157a-48f5-a6dc-4b063a5e39e4;In vitro and in vivo effect of human lactoferrin on glioblastoma growth;Arcella et al.;2015;10.3171/2014.12.JNS14512;JOURNAL OF NEUROSURGERY;3,443;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;not reported;NA;5000;NA;NA;NA;FALSE;other;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;5;0;0,4375;TRUE;96000;3000;Cell number;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd4ac184c-157a-48f5-a6dc-4b063a5e39e4;In vitro and in vivo effect of human lactoferrin on glioblastoma growth;Arcella et al.;2015;10.3171/2014.12.JNS14512;JOURNAL OF NEUROSURGERY;3,443;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;other;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;1;0,4375;TRUE;10000;1000;Cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd4ac184c-157a-48f5-a6dc-4b063a5e39e4;In vitro and in vivo effect of human lactoferrin on glioblastoma growth;Arcella et al.;2015;10.3171/2014.12.JNS14512;JOURNAL OF NEUROSURGERY;3,443;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;other;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;1;0,4375;TRUE;17500;1000;Cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd4ac184c-157a-48f5-a6dc-4b063a5e39e4;In vitro and in vivo effect of human lactoferrin on glioblastoma growth;Arcella et al.;2015;10.3171/2014.12.JNS14512;JOURNAL OF NEUROSURGERY;3,443;not reported at all;not reported;Thermo Fischer Scientific, US;not reported;;TRUE;5000;NA;NA;FALSE;NA;other;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;5;1;0,4375;TRUE;77500;1000;Cell number;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd584db75-fc52-4781-8280-3e89a1e6ace0;Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O-6-methylguanine DNA-methyltransferase;Wang et al.;2012;10.1007/s10072-012-1257-9;Neurological Sciences;1,412;it is reported that there are no conflicts of interest ;not reported;No use of FBS reported;not reported;not reported;NA;10000;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;other;;NA;NA;FALSE;5;0;0,375;FALSE;100;1;Viable cells (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd584db75-fc52-4781-8280-3e89a1e6ace0;Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O-6-methylguanine DNA-methyltransferase;Wang et al.;2012;10.1007/s10072-012-1257-9;Neurological Sciences;1,412;it is reported that there are no conflicts of interest ;not reported;No use of FBS reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;other;;NA;NA;FALSE;5;1000;0,375;FALSE;23,5;2,8;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd584db75-fc52-4781-8280-3e89a1e6ace0;Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O-6-methylguanine DNA-methyltransferase;Wang et al.;2012;10.1007/s10072-012-1257-9;Neurological Sciences;1,412;it is reported that there are no conflicts of interest ;not reported;No use of FBS reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;other;;NA;NA;FALSE;5;25;0,375;FALSE;93,5;1;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd584db75-fc52-4781-8280-3e89a1e6ace0;Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O-6-methylguanine DNA-methyltransferase;Wang et al.;2012;10.1007/s10072-012-1257-9;Neurological Sciences;1,412;it is reported that there are no conflicts of interest ;not reported;No use of FBS reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;other;;NA;NA;FALSE;5;250;0,375;FALSE;86,5;5,5;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd584db75-fc52-4781-8280-3e89a1e6ace0;Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O-6-methylguanine DNA-methyltransferase;Wang et al.;2012;10.1007/s10072-012-1257-9;Neurological Sciences;1,412;it is reported that there are no conflicts of interest ;not reported;No use of FBS reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;other;;NA;NA;FALSE;5;50;0,375;FALSE;90,8;5,5;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd584db75-fc52-4781-8280-3e89a1e6ace0;Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O-6-methylguanine DNA-methyltransferase;Wang et al.;2012;10.1007/s10072-012-1257-9;Neurological Sciences;1,412;it is reported that there are no conflicts of interest ;not reported;No use of FBS reported;not reported;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;other;;NA;NA;FALSE;5;500;0,375;FALSE;78,6;6;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;DMSO;NA;5000;NA;NA;NA;FALSE;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,6875;TRUE;100,4;9,6;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;DMSO;NA;5000;NA;NA;NA;FALSE;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,6875;TRUE;98,5;6,4;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;DMSO;NA;5000;NA;NA;NA;FALSE;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,6875;TRUE;98,2;5,6;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;1000;0,6875;TRUE;53;3,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;1000;0,6875;TRUE;36;9,6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;1000;0,6875;TRUE;25,8;4,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;125;0,6875;TRUE;59,9;5,1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;125;0,6875;TRUE;79,3;7,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;125;0,6875;TRUE;71,4;5,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;15,6;0,6875;TRUE;93,8;6,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;15,6;0,6875;TRUE;87,6;12;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;15,6;0,6875;TRUE;84,7;7,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;250;0,6875;TRUE;53;3,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;250;0,6875;TRUE;70;10,1;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;250;0,6875;TRUE;65,5;2,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;3,9;0,6875;TRUE;107,8;4,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;3,9;0,6875;TRUE;94;2,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;3,9;0,6875;TRUE;90,8;4,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;31,2;0,6875;TRUE;83,4;8,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;31,2;0,6875;TRUE;87;7,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;31,2;0,6875;TRUE;81,5;7,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;500;0,6875;TRUE;53,5;3,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;500;0,6875;TRUE;54,3;11;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;500;0,6875;TRUE;59,8;3,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;62,5;0,6875;TRUE;71,9;6,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;62,5;0,6875;TRUE;86,2;7,3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;62,5;0,6875;TRUE;79,6;6,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;7,8;0,6875;TRUE;97,7;6,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;7,8;0,6875;TRUE;88,9;6,4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd5df5767-86c8-4c6b-96d0-acad2db2d863;Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents;Doganlar et al.;2020;10.1016/j.ecoenv.2020.110940;Ecotoxicology and Environmental Safety;4,872;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;low glucose & pyruvate;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;7,8;0,6875;TRUE;87,6;3,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;NA;200;NA;40;NA;FALSE;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;3;0;0,6875;TRUE;100;6,8;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;NA;200;NA;40;NA;FALSE;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;4;0;0,6875;TRUE;100;1,2;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;NA;200;NA;40;NA;FALSE;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;5;0;0,6875;TRUE;100;2,2;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;NA;200;NA;40;NA;FALSE;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;6;0;0,6875;TRUE;100;6,3;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;3;100;0,6875;TRUE;73,9;2,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;4;100;0,6875;TRUE;72,7;2,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;5;100;0,6875;TRUE;66,4;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;6;100;0,6875;TRUE;60,3;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;3;200;0,6875;TRUE;59,1;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;4;200;0,6875;TRUE;52,3;1,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;5;200;0,6875;TRUE;36,8;0,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;6;200;0,6875;TRUE;2,6;4,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;3;50;0,6875;TRUE;93,2;1,2;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;4;50;0,6875;TRUE;90,9;2,3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;5;50;0,6875;TRUE;79;6,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd7b2b063-f0a5-496a-92f0-bb7a5920e241;Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz 100 G);Akbarnejad et al.;2017;10.1016/j.biopha.2017.05.050;BIOMEDICINE & PHARMACOTHERAPY ;3,457;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;;TRUE;200;NA;40;FALSE;NA;MTT, colorimetric;6;SEM;reported;FALSE;other;;NA;80;FALSE;6;50;0,6875;TRUE;70,4;4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingd96e3310-73e6-4d24-b7cb-bdcaf1ec0efd;Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery;Wu et al.;2015;10.3109/10717544.2015.1058434;DRUG DELIVERY;4,843;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;medium without DMSO;NA;5000;NA;NA;NA;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,5;FALSE;0;0;Inhibition rate (%);TRUE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd96e3310-73e6-4d24-b7cb-bdcaf1ec0efd;Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery;Wu et al.;2015;10.3109/10717544.2015.1058434;DRUG DELIVERY;4,843;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0,1;0,5;FALSE;16;1,8;Inhibition rate (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd96e3310-73e6-4d24-b7cb-bdcaf1ec0efd;Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery;Wu et al.;2015;10.3109/10717544.2015.1058434;DRUG DELIVERY;4,843;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0,5;0,5;FALSE;16,5;1,9;Inhibition rate (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd96e3310-73e6-4d24-b7cb-bdcaf1ec0efd;Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery;Wu et al.;2015;10.3109/10717544.2015.1058434;DRUG DELIVERY;4,843;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;1;0,5;FALSE;18,4;2,4;Inhibition rate (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingd96e3310-73e6-4d24-b7cb-bdcaf1ec0efd;Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery;Wu et al.;2015;10.3109/10717544.2015.1058434;DRUG DELIVERY;4,843;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;5000;NA;NA;FALSE;NA;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;5;0,5;FALSE;23,5;1,9;Inhibition rate (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingdb764b96-86d1-4aee-961e-b85e0cda55cf;Downregulation of Id2 increases chemosensitivity of glioma;Zhao et al.;2015;10.1007/s13277-015-3055-5;Tumor Biology;2,926;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;NA;0,4375;FALSE;1,63;0,24;Cell number (x1000);FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingdb764b96-86d1-4aee-961e-b85e0cda55cf;Downregulation of Id2 increases chemosensitivity of glioma;Zhao et al.;2015;10.1007/s13277-015-3055-5;Tumor Biology;2,926;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;NA;0,4375;FALSE;1,45;0,3;Cell number (x1000);FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingdb764b96-86d1-4aee-961e-b85e0cda55cf;Downregulation of Id2 increases chemosensitivity of glioma;Zhao et al.;2015;10.1007/s13277-015-3055-5;Tumor Biology;2,926;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;NA;0,4375;FALSE;1,33;0,28;Cell number (x1000);FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingdb764b96-86d1-4aee-961e-b85e0cda55cf;Downregulation of Id2 increases chemosensitivity of glioma;Zhao et al.;2015;10.1007/s13277-015-3055-5;Tumor Biology;2,926;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;Temozolomide is the control group of the experiment;TRUE;10000;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;4;NA;0,4375;FALSE;1,1;0,26;Cell number (x1000);FALSE;NA;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;3000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,5;TRUE;100;0,5;Cell surviving rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;3000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;100;0,5;Cell surviving rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;3000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;7;0;0,5;TRUE;100;0,5;Cell surviving rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;1000;0,5;TRUE;34,4;2,6;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;1000;0,5;TRUE;29,5;2,1;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;7;1000;0,5;TRUE;26,5;4,2;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;200;0,5;TRUE;86,3;1,1;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;200;0,5;TRUE;84;0,5;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;7;200;0,5;TRUE;74,8;0,5;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;400;0,5;TRUE;701,8;3,1;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;400;0,5;TRUE;77,7;2,1;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;7;400;0,5;TRUE;64;2,6;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;800;0,5;TRUE;68,5;5,7;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;800;0,5;TRUE;64,4;1,6;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingde2d96d2-bbff-462a-b344-fa179031f126;Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication;Wang et al.;2018;10.3892/ijo.2017.4188;International Journal of Oncology;3,571;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;7;800;0,5;TRUE;32,9;3,1;Cell surviving rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinge1b12f59-eddd-46a8-871e-fc28b5d14d06;Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma;Wu et al.;2015;10.3892/mmr.2015.4087;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;DMSO;NA;6000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5625;TRUE;100;3,7;% of control;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge1b12f59-eddd-46a8-871e-fc28b5d14d06;Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma;Wu et al.;2015;10.3892/mmr.2015.4087;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;100;0,5625;TRUE;87,6;6,2;% of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge1b12f59-eddd-46a8-871e-fc28b5d14d06;Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma;Wu et al.;2015;10.3892/mmr.2015.4087;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;300;0,5625;TRUE;65,5;8,3;% of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge1b12f59-eddd-46a8-871e-fc28b5d14d06;Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma;Wu et al.;2015;10.3892/mmr.2015.4087;MOLECULAR MEDICINE REPORTS ;1,559;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;500;0,5625;TRUE;42,3;5,2;% of control;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge3d07e37-7606-446e-bac2-39fbda6d045d;STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression;Kohsaka et al.;2012;10.1158/1535-7163.MCT-11-0801;MOLECULAR CANCER THERAPEUTICS ;5,599;it is reported that there are no conflicts of interest ;not reported;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;other;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;5;60;0,4375;TRUE;0,35;0,06;Proliferation (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missinge655f8ff-ca46-4d8e-b718-9d613cec8733;Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide;Koukourakis et al.;2017;10.1016/j.bbrc.2017.07.138;Biochemical and Biophysical Research Communications;2,559;not reported at all;Penicillin + Streptomycin;Other source;not reported;not reported;NA;250;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;not reported;TRUE;ATCC;;NA;80;TRUE;0;0;0,5625;TRUE;0,5;0,1;Fold change compared to control (day 0);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge655f8ff-ca46-4d8e-b718-9d613cec8733;Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide;Koukourakis et al.;2017;10.1016/j.bbrc.2017.07.138;Biochemical and Biophysical Research Communications;2,559;not reported at all;Penicillin + Streptomycin;Other source;not reported;not reported;NA;250;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;not reported;TRUE;ATCC;;NA;80;TRUE;2;0;0,5625;TRUE;2,6;0,3;Fold change compared to control (day 0);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge655f8ff-ca46-4d8e-b718-9d613cec8733;Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide;Koukourakis et al.;2017;10.1016/j.bbrc.2017.07.138;Biochemical and Biophysical Research Communications;2,559;not reported at all;Penicillin + Streptomycin;Other source;not reported;not reported;NA;250;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;not reported;TRUE;ATCC;;NA;80;TRUE;4;0;0,5625;TRUE;6,9;0,6;Fold change compared to control (day 0);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge655f8ff-ca46-4d8e-b718-9d613cec8733;Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide;Koukourakis et al.;2017;10.1016/j.bbrc.2017.07.138;Biochemical and Biophysical Research Communications;2,559;not reported at all;Penicillin + Streptomycin;Other source;not reported;not reported;NA;250;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;not reported;TRUE;ATCC;;NA;80;TRUE;6;0;0,5625;TRUE;11,4;1;Fold change compared to control (day 0);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge655f8ff-ca46-4d8e-b718-9d613cec8733;Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide;Koukourakis et al.;2017;10.1016/j.bbrc.2017.07.138;Biochemical and Biophysical Research Communications;2,559;not reported at all;Penicillin + Streptomycin;Other source;not reported;;FALSE;250;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;not reported;TRUE;ATCC;;NA;80;TRUE;0;65;0,5625;TRUE;0,5;0,1;Fold change compared to control (day 0);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge655f8ff-ca46-4d8e-b718-9d613cec8733;Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide;Koukourakis et al.;2017;10.1016/j.bbrc.2017.07.138;Biochemical and Biophysical Research Communications;2,559;not reported at all;Penicillin + Streptomycin;Other source;not reported;;FALSE;250;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;not reported;TRUE;ATCC;;NA;80;TRUE;2;65;0,5625;TRUE;1,6;0,7;Fold change compared to control (day 0);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge655f8ff-ca46-4d8e-b718-9d613cec8733;Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide;Koukourakis et al.;2017;10.1016/j.bbrc.2017.07.138;Biochemical and Biophysical Research Communications;2,559;not reported at all;Penicillin + Streptomycin;Other source;not reported;;FALSE;250;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;not reported;TRUE;ATCC;;NA;80;TRUE;4;65;0,5625;TRUE;4,7;0,4;Fold change compared to control (day 0);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge655f8ff-ca46-4d8e-b718-9d613cec8733;Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide;Koukourakis et al.;2017;10.1016/j.bbrc.2017.07.138;Biochemical and Biophysical Research Communications;2,559;not reported at all;Penicillin + Streptomycin;Other source;not reported;;FALSE;250;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;not reported;TRUE;ATCC;;NA;80;TRUE;6;65;0,5625;TRUE;6,4;0,6;Fold change compared to control (day 0);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;2000;NA;NA;NA;FALSE;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;0;0,625;TRUE;1;0,05;Relative cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;100;0,625;TRUE;0,64;0,04;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;100;0,625;TRUE;1;0,06;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;100;0,625;TRUE;0,92;0,02;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;100;0,625;TRUE;0,79;0,04;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;100;0,625;TRUE;0,75;0,03;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;150;0,625;TRUE;0,33;0,02;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;200;0,625;TRUE;0,3;0,03;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge663f863-adf2-419b-ada9-bebffcdfd05a;Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation;Chen et al.;2019;10.3892/ol.2019.10235;ONCOLOGY LETTERS;2,311;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;2000;NA;NA;FALSE;NA;other;3;SEM;reported;TRUE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;50;0,625;TRUE;0,86;0,03;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missinge76f5704-1e0d-4416-97d8-f47b618ccd3d;Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells;Zheng et al.;2017;10.3892/ijo.2017.4033;INTERNATIONAL JOURNAL OF ONCOLOGY;3,333;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;not reported;NA;NA;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,4375;TRUE;100;1;Survival rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge76f5704-1e0d-4416-97d8-f47b618ccd3d;Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells;Zheng et al.;2017;10.3892/ijo.2017.4033;INTERNATIONAL JOURNAL OF ONCOLOGY;3,333;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;500;0,4375;TRUE;48,7;2,5;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge76f5704-1e0d-4416-97d8-f47b618ccd3d;Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells;Zheng et al.;2017;10.3892/ijo.2017.4033;INTERNATIONAL JOURNAL OF ONCOLOGY;3,333;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;1000;0,4375;TRUE;47,6;2,4;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge76f5704-1e0d-4416-97d8-f47b618ccd3d;Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells;Zheng et al.;2017;10.3892/ijo.2017.4033;INTERNATIONAL JOURNAL OF ONCOLOGY;3,333;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;1500;0,4375;TRUE;38,4;2,9;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge76f5704-1e0d-4416-97d8-f47b618ccd3d;Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells;Zheng et al.;2017;10.3892/ijo.2017.4033;INTERNATIONAL JOURNAL OF ONCOLOGY;3,333;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;2000;0,4375;TRUE;34,8;2,9;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge76f5704-1e0d-4416-97d8-f47b618ccd3d;Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells;Zheng et al.;2017;10.3892/ijo.2017.4033;INTERNATIONAL JOURNAL OF ONCOLOGY;3,333;not reported at all;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;not reported;;FALSE;NA;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;2;2500;0,4375;TRUE;28,5;1,5;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge8c88cd2-830a-4b62-95e8-18fdeaa25347;Combined effects of mesenchymal stem cells carrying cytosine deaminase gene with 5-fluorocytosine and temozolomide in orthotopic glioma model;Chang et al.;2020;;American Journal of Cancer Research ;5,177;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;NA;1000;NA;NA;NA;FALSE;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;5;0;0,6875;TRUE;100;1;Survival rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge8c88cd2-830a-4b62-95e8-18fdeaa25347;Combined effects of mesenchymal stem cells carrying cytosine deaminase gene with 5-fluorocytosine and temozolomide in orthotopic glioma model;Chang et al.;2020;;American Journal of Cancer Research ;5,177;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;TRUE;1000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;5;1;0,6875;TRUE;95;3;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge8c88cd2-830a-4b62-95e8-18fdeaa25347;Combined effects of mesenchymal stem cells carrying cytosine deaminase gene with 5-fluorocytosine and temozolomide in orthotopic glioma model;Chang et al.;2020;;American Journal of Cancer Research ;5,177;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;TRUE;1000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;5;10;0,6875;TRUE;91;4;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge8c88cd2-830a-4b62-95e8-18fdeaa25347;Combined effects of mesenchymal stem cells carrying cytosine deaminase gene with 5-fluorocytosine and temozolomide in orthotopic glioma model;Chang et al.;2020;;American Journal of Cancer Research ;5,177;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;TRUE;1000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;5;100;0,6875;TRUE;53;6;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge8c88cd2-830a-4b62-95e8-18fdeaa25347;Combined effects of mesenchymal stem cells carrying cytosine deaminase gene with 5-fluorocytosine and temozolomide in orthotopic glioma model;Chang et al.;2020;;American Journal of Cancer Research ;5,177;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Hyclone Laboratories Inc, US;high glucose & pyruvate;DMSO;TRUE;1000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;TRUE;ATCC;;NA;NA;FALSE;5;300;0,6875;TRUE;42;5;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;not reported;NA;50000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,4375;TRUE;102,1;4,7;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;not reported;NA;50000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;0;0,4375;TRUE;100,6;3,7;Cell viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;10;0,4375;TRUE;105,7;12,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;10;0,4375;TRUE;92,8;4;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,4375;TRUE;105,6;6,3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;100;0,4375;TRUE;81,9;16,6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;200;0,4375;TRUE;114;4,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;200;0,4375;TRUE;79,4;5,8;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;25;0,4375;TRUE;106,7;17,6;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;25;0,4375;TRUE;82,4;5,7;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;5;0,4375;TRUE;93,3;8,3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;5;0,4375;TRUE;92,3;7,3;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;50;0,4375;TRUE;106,2;46,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;50;0,4375;TRUE;79,9;11,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;3;75;0,4375;TRUE;110,9;12,5;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missinge97857cd-aa4e-4af4-9448-6f6973fd6755;The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells;Atif et al.;2015;10.1371/journal.pone.0131441;PLoS One;3,057;it is reported that there are conflicts of interest ;not reported;not reported;not reported;;TRUE;50000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;ATCC;;NA;NA;FALSE;6;75;0,4375;TRUE;79,4;10,9;Cell viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;no data missing;no data points missingead849ed-5eaa-4015-a924-d03a30dbfebb;EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition;Zhang et al.;2014;10.1007/s11060-014-1604-1;JOURNAL OF NEURO-ONCOLOGY;3,07;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;5000;NA;NA;NA;FALSE;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;0;0,5;TRUE;0;0;Inhibitory ratio (%);TRUE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingead849ed-5eaa-4015-a924-d03a30dbfebb;EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition;Zhang et al.;2014;10.1007/s11060-014-1604-1;JOURNAL OF NEURO-ONCOLOGY;3,07;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;100;0,5;TRUE;22;1;Inhibitory ratio (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingead849ed-5eaa-4015-a924-d03a30dbfebb;EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition;Zhang et al.;2014;10.1007/s11060-014-1604-1;JOURNAL OF NEURO-ONCOLOGY;3,07;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;200;0,5;TRUE;48;3;Inhibitory ratio (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingead849ed-5eaa-4015-a924-d03a30dbfebb;EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition;Zhang et al.;2014;10.1007/s11060-014-1604-1;JOURNAL OF NEURO-ONCOLOGY;3,07;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;300;0,5;TRUE;62;3;Inhibitory ratio (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingead849ed-5eaa-4015-a924-d03a30dbfebb;EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition;Zhang et al.;2014;10.1007/s11060-014-1604-1;JOURNAL OF NEURO-ONCOLOGY;3,07;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;400;0,5;TRUE;65;2;Inhibitory ratio (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingead849ed-5eaa-4015-a924-d03a30dbfebb;EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition;Zhang et al.;2014;10.1007/s11060-014-1604-1;JOURNAL OF NEURO-ONCOLOGY;3,07;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;5000;NA;NA;FALSE;NA;CCK8, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;50;0,5;TRUE;14;4;Inhibitory ratio (%);TRUE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;2500;100;25;NA;FALSE;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;0;0,5;TRUE;1;0,03;Proliferation;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;2500;100;25;NA;FALSE;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;0;0,5;TRUE;1;0,04;Proliferation;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;100;0,5;TRUE;0,12;0,03;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;100;0,5;TRUE;0,09;0,05;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;1000;0,5;TRUE;0,07;0,06;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;20;0,5;TRUE;0,63;0,03;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;20;0,5;TRUE;0,62;0,01;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;200;0,5;TRUE;0,09;0,03;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;200;0,5;TRUE;0,07;0,03;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;300;0,5;TRUE;0,08;0,03;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;300;0,5;TRUE;0,05;0,02;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;40;0,5;TRUE;0,45;0,03;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;40;0,5;TRUE;0,42;0,03;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;400;0,5;TRUE;0,08;0,04;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;400;0,5;TRUE;0,06;0,01;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;500;0,5;TRUE;0,07;0,03;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;500;0,5;TRUE;0,04;0,01;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;60;0,5;TRUE;0,36;0,04;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;60;0,5;TRUE;0,33;0,05;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;600;0,5;TRUE;0,06;0,04;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;80;0,5;TRUE;0,19;0,04;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingee686ee8-038b-47d2-9995-37183f9c51be;Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells;Yang et al.;2018;10.1038/s41417-018-0040-3;CANCER GENE THERAPY;4,681;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;FALSE;2500;100;25;FALSE;NA;MTT, colorimetric;3;SD;not reported;FALSE;ATCC;;NA;NA;TRUE;5;80;0,5;TRUE;0,2;0,06;Proliferation;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;DMSO;NA;24000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;0;0;0,6875;TRUE;0,05;0,01;A590 - A630;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;DMSO;NA;24000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;1;0;0,6875;TRUE;0,08;0,01;A590 - A630;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;DMSO;NA;24000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;2;0;0,6875;TRUE;0,11;0,01;A590 - A630;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;DMSO;NA;24000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;3;0;0,6875;TRUE;0,16;0,03;A590 - A630;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;DMSO;NA;24000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;4;0;0,6875;TRUE;0,3;0,04;A590 - A630;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;DMSO;NA;24000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;5;0;0,6875;TRUE;0,48;0,05;A590 - A630;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;0;100;0,6875;TRUE;0,05;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;1;100;0,6875;TRUE;0,05;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;2;100;0,6875;TRUE;0,05;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;3;100;0,6875;TRUE;0,07;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;4;100;0,6875;TRUE;0,08;0,02;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;5;100;0,6875;TRUE;0,1;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;0;12,5;0,6875;TRUE;0,05;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;1;12,5;0,6875;TRUE;0,08;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;2;12,5;0,6875;TRUE;0,09;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;3;12,5;0,6875;TRUE;0,12;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;4;12,5;0,6875;TRUE;0,14;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;5;12,5;0,6875;TRUE;0,19;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;0;25;0,6875;TRUE;0,05;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;1;25;0,6875;TRUE;0,06;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;2;25;0,6875;TRUE;0,09;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;3;25;0,6875;TRUE;0,1;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;4;25;0,6875;TRUE;0,13;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;5;25;0,6875;TRUE;0,18;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;0;50;0,6875;TRUE;0,05;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;1;50;0,6875;TRUE;0,06;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;2;50;0,6875;TRUE;0,07;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;3;50;0,6875;TRUE;0,11;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;4;50;0,6875;TRUE;0,12;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf04bbf0d-ad97-456f-b72e-d979a3d06abd;GADD45A plays a protective role against temozolomide treatment in glioblastoma cells;Wang et al.;2017;10.1038/s41598-017-06851-3;Scientific Reports;4,122;it is reported that there are no conflicts of interest ;not reported;Hyclone Laboratories Inc, US;not reported;;TRUE;24000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;TRUE;ATCC;35;NA;NA;FALSE;5;50;0,6875;TRUE;0,16;0,01;A590 - A630;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf08c5376-874b-4753-b626-98f3d9870491;G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis;Bittencourt et al.;2019;10.1007/s11060-019-03252-6;Journal of Neuro-Oncology;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0,01;0,625;TRUE;94,2;12,2;Cell survival (%) / MTT response;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf08c5376-874b-4753-b626-98f3d9870491;G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis;Bittencourt et al.;2019;10.1007/s11060-019-03252-6;Journal of Neuro-Oncology;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0,1;0,625;TRUE;94,7;8,2;Cell survival (%) / MTT response;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf08c5376-874b-4753-b626-98f3d9870491;G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis;Bittencourt et al.;2019;10.1007/s11060-019-03252-6;Journal of Neuro-Oncology;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;1;0,625;TRUE;113,2;12,4;Cell survival (%) / MTT response;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf08c5376-874b-4753-b626-98f3d9870491;G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis;Bittencourt et al.;2019;10.1007/s11060-019-03252-6;Journal of Neuro-Oncology;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;10;0,625;TRUE;112,7;12,2;Cell survival (%) / MTT response;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf08c5376-874b-4753-b626-98f3d9870491;G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis;Bittencourt et al.;2019;10.1007/s11060-019-03252-6;Journal of Neuro-Oncology;3,267;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Other source;high glucose & pyruvate;;TRUE;10000;NA;NA;FALSE;NA;MTT, colorimetric;3;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,625;TRUE;76,7;11,7;Cell survival (%) / MTT response;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;DMSO;NA;6000;NA;NA;NA;FALSE;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;0;0,625;TRUE;100;1;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;DMSO;NA;6000;NA;NA;NA;FALSE;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;1;0;0,625;TRUE;100;0;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;DMSO;NA;6000;NA;NA;NA;FALSE;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;0;0,625;TRUE;100;0;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;1;1000;0,625;TRUE;88,5;7;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;1000;0,625;TRUE;67;9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;0;400;0,625;TRUE;100;1;Cell growth (% of control at time zero);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;1;400;0,625;TRUE;155,5;7;Cell growth (% of control at time zero);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;400;0,625;TRUE;240;20;Cell growth (% of control at time zero);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;Sulforhodamine B (SRB), colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;3;400;0,625;TRUE;370;15;Cell growth (% of control at time zero);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;400;0,625;TRUE;91,5;3;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;1;500;0,625;TRUE;103;3;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;500;0,625;TRUE;90;3;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;1;750;0,625;TRUE;97,5;5;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;750;0,625;TRUE;84,5;6;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;1;875;0,625;TRUE;92;4;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf0c825a5-5083-4867-8af2-38cf451117c6;Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma;Morais et al.;2019;10.1093/hmg/ddz152;HUMAN MOLECULAR GENETICS;5,101;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;high glucose & pyruvate;;FALSE;6000;NA;NA;FALSE;NA;other;4;SD;reported;FALSE;colleagues;;NA;NA;FALSE;2;875;0,625;TRUE;74,5;8;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;data points missingf2a0de99-cc26-41ee-9b95-269ba42b2051;Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in glioma;Zou et al.;2014;10.3892/mmr.2014.2151;MOLECULAR MEDICINE REPORTS ;1,554;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;0;0,5625;TRUE;1;0,05;Relative Cell Viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf2a0de99-cc26-41ee-9b95-269ba42b2051;Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in glioma;Zou et al.;2014;10.3892/mmr.2014.2151;MOLECULAR MEDICINE REPORTS ;1,554;it is reported that there are no conflicts of interest ;not reported;Other source;not reported;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;6;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;3;100;0,5625;TRUE;0,81;0,06;Relative Cell Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;20000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;0;0;0,5;TRUE;1,1;0,07;Cell survival (Cell number * 10^4);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;20000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;0;0,5;TRUE;1,29;0,06;Cell survival (Cell number * 10^4);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;20000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;0;0,5;TRUE;1,4;0,06;Cell survival (Cell number * 10^4);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;20000;NA;NA;NA;FALSE;Trypan Blue exclusion, cell counting;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;1,58;0,11;Cell survival (Cell number * 10^4);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;not reported;NA;3000;NA;NA;NA;FALSE;other;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;0;0,5;TRUE;1,22;0,1;Cell proliferation, OD450-OD690;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;20000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;0;100;0,5;TRUE;1,13;0,06;Cell survival (Cell number * 10^4);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;20000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,5;TRUE;1,05;0,08;Cell survival (Cell number * 10^4);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;20000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;2;100;0,5;TRUE;0,82;0,07;Cell survival (Cell number * 10^4);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;20000;NA;NA;FALSE;NA;Trypan Blue exclusion, cell counting;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5;TRUE;0,62;0,03;Cell survival (Cell number * 10^4);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf3d71ce9-7c96-4de2-aec1-9d4e3cdb959a;Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway;Chio et al.;2018;10.1016/j.phymed.2018.06.012;Phytomedicine;4,18;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;not reported;not reported;;TRUE;3000;NA;NA;FALSE;NA;other;6;SEM;reported;FALSE;ATCC;;NA;NA;FALSE;3;100;0,5;TRUE;0,98;0,09;Cell proliferation, OD450-OD690;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf519c5fc-9a40-4cd0-a437-e65cd2097d33;Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation;Shi et al.;2014;10.1007/s13277-014-2644-z;Tumor Biology;3,611;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;medium without DMSO;NA;3200;NA;NA;NA;TRUE;WST-1 assay, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;0;0,5625;FALSE;100;1;Viability (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf519c5fc-9a40-4cd0-a437-e65cd2097d33;Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation;Shi et al.;2014;10.1007/s13277-014-2644-z;Tumor Biology;3,611;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3200;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;0,515063018;0,5625;FALSE;91,9;2;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf519c5fc-9a40-4cd0-a437-e65cd2097d33;Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation;Shi et al.;2014;10.1007/s13277-014-2644-z;Tumor Biology;3,611;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3200;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;5,15063018;0,5625;FALSE;86,3;2;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf519c5fc-9a40-4cd0-a437-e65cd2097d33;Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation;Shi et al.;2014;10.1007/s13277-014-2644-z;Tumor Biology;3,611;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3200;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;51,5063018;0,5625;FALSE;72;3,7;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf519c5fc-9a40-4cd0-a437-e65cd2097d33;Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation;Shi et al.;2014;10.1007/s13277-014-2644-z;Tumor Biology;3,611;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3200;NA;NA;FALSE;NA;WST-1 assay, colorimetric;3;SEM;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;515,063018;0,5625;FALSE;64;2;Viability (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf6ee1fa2-27e8-423e-b13d-1c8935438f4f;Synergistic inhibition of human glioma cell line by temozolomide and PAMAM-mediated miR-21i;Qian et al.;2012;10.1002/app.37823;Journal of Applied Polymer Science;1,395;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;DMSO;NA;3000;NA;NA;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0,1666;0;0,5;TRUE;100;1;Viable cells (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf6ee1fa2-27e8-423e-b13d-1c8935438f4f;Synergistic inhibition of human glioma cell line by temozolomide and PAMAM-mediated miR-21i;Qian et al.;2012;10.1002/app.37823;Journal of Applied Polymer Science;1,395;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0,1666;22,5;0,5;TRUE;55,3;0,5;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf6ee1fa2-27e8-423e-b13d-1c8935438f4f;Synergistic inhibition of human glioma cell line by temozolomide and PAMAM-mediated miR-21i;Qian et al.;2012;10.1002/app.37823;Journal of Applied Polymer Science;1,395;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0,1666;40;0,5;TRUE;21,3;1;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf6ee1fa2-27e8-423e-b13d-1c8935438f4f;Synergistic inhibition of human glioma cell line by temozolomide and PAMAM-mediated miR-21i;Qian et al.;2012;10.1002/app.37823;Journal of Applied Polymer Science;1,395;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0,1666;7,5;0,5;TRUE;84,5;1,9;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf6ee1fa2-27e8-423e-b13d-1c8935438f4f;Synergistic inhibition of human glioma cell line by temozolomide and PAMAM-mediated miR-21i;Qian et al.;2012;10.1002/app.37823;Journal of Applied Polymer Science;1,395;not reported at all;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;3000;NA;NA;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0,1666;15;0,5;TRUE;61,4;2,4;Viable cells (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingf72cceb0-db8a-40e0-b989-887271dc61ec;Downregulation of miR-155 inhibits proliferation and enhances chemosensitivity to Temozolomide in glioma cells;Meng et al.;2017;;International Journal of Clinical and Experimental Pathology ;1,396;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;FALSE;NA;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;0;0;0,375;FALSE;100;6;Survival rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missingf72cceb0-db8a-40e0-b989-887271dc61ec;Downregulation of miR-155 inhibits proliferation and enhances chemosensitivity to Temozolomide in glioma cells;Meng et al.;2017;;International Journal of Clinical and Experimental Pathology ;1,396;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;FALSE;NA;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;0;100;0,375;FALSE;37;3;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missingf72cceb0-db8a-40e0-b989-887271dc61ec;Downregulation of miR-155 inhibits proliferation and enhances chemosensitivity to Temozolomide in glioma cells;Meng et al.;2017;;International Journal of Clinical and Experimental Pathology ;1,396;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Sigma-Aldrich, US;not reported;not reported;FALSE;NA;NA;NA;FALSE;FALSE;MTT, colorimetric;not reported;SD;reported;FALSE;ATCC;;NA;NA;FALSE;1;100;0,375;FALSE;42;2;Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number clear;data missing;no data points missingfa8c41e6-ab4d-4e97-a846-75208625a8cc;Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy;Ma et al.;2018;;Annals of Clinical & Laboratory Science;0,96;not reported at all;not reported;not reported;not reported;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;100;0,1875;FALSE;0,75;0,05;relative cell growth;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingfa8c41e6-ab4d-4e97-a846-75208625a8cc;Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy;Ma et al.;2018;;Annals of Clinical & Laboratory Science;0,96;not reported at all;not reported;not reported;not reported;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;100;0,1875;FALSE;1,49;0,1;relative cell growth;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingfa8c41e6-ab4d-4e97-a846-75208625a8cc;Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy;Ma et al.;2018;;Annals of Clinical & Laboratory Science;0,96;not reported at all;not reported;not reported;not reported;;FALSE;2000;NA;NA;FALSE;NA;CCK8, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;100;0,1875;FALSE;1,875;0,16;relative cell growth;FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingfa8c41e6-ab4d-4e97-a846-75208625a8cc;Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy;Ma et al.;2018;;Annals of Clinical & Laboratory Science;0,96;not reported at all;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;CCK8, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;0;0;0,1875;FALSE;0,7;0,09;relative cell growth;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingfa8c41e6-ab4d-4e97-a846-75208625a8cc;Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy;Ma et al.;2018;;Annals of Clinical & Laboratory Science;0,96;not reported at all;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;CCK8, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;1;0;0,1875;FALSE;1,68;0,09;relative cell growth;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingfa8c41e6-ab4d-4e97-a846-75208625a8cc;Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy;Ma et al.;2018;;Annals of Clinical & Laboratory Science;0,96;not reported at all;not reported;not reported;not reported;not reported;NA;2000;NA;NA;NA;FALSE;CCK8, colorimetric;not reported;SD;reported;FALSE;Cell Bank of the Chinese Academy of Sciences (Shanghai, China);;NA;NA;FALSE;2;0;0,1875;FALSE;2,48;0,19;relative cell growth;FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingfa97ee03-bef2-4837-9b71-15bf91056323;High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors;Cunha et al.;2017;10.1093/hmg/ddx323;Human Molecular Genetics;4,902;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;not reported;NA;18000;NA;NA;NA;FALSE;Alamar Blue, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;1;0;0,5625;TRUE;100;0,5;Cell viability (% of control);FALSE;TRUE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingfa97ee03-bef2-4837-9b71-15bf91056323;High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors;Cunha et al.;2017;10.1093/hmg/ddx323;Human Molecular Genetics;4,902;it is reported that there are no conflicts of interest ;Penicillin + Streptomycin;Thermo Fischer Scientific, US;not reported;;TRUE;18000;NA;NA;FALSE;NA;Alamar Blue, colorimetric;3;SD;reported;FALSE;colleagues;;NA;NA;FALSE;1;200;0,5625;TRUE;98,3;4,9;Cell viability (% of control);FALSE;FALSE;not reported;not reported;not reported;not available;calculation intransparent;number unclear;no data missing;no data points missingfd93d05d-13dc-42fe-871c-5e020977592a;Verbascoside inhibits glioblastoma cell proliferation migration and invasion while promoting apoptosis through upregulation of protein tyrosine phosphatase SHP-1 and inhibition of STAT3 phosphorylation;Jia et al.;2018;10.1159/000491067;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY;5,11;it is reported that there are no conflicts of interest ;not reported;not reported;high glucose & pyruvate;DMSO;NA;NA;NA;50;NA;FALSE;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;0;0,5;TRUE;99;3,2; Survival rate (%);FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingfd93d05d-13dc-42fe-871c-5e020977592a;Verbascoside inhibits glioblastoma cell proliferation migration and invasion while promoting apoptosis through upregulation of protein tyrosine phosphatase SHP-1 and inhibition of STAT3 phosphorylation;Jia et al.;2018;10.1159/000491067;CELLULAR PHYSIOLOGY AND BIOCHEMISTRY;5,11;it is reported that there are no conflicts of interest ;not reported;not reported;high glucose & pyruvate;;FALSE;NA;NA;50;FALSE;NA;MTT, colorimetric;3;SD;reported;FALSE;other;;NA;NA;FALSE;1;300;0,5;TRUE;77;4,3; Survival rate (%);FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingff2133b8-10bc-415d-b23a-e4327f028d59;Effect of temozolomide on the viability of musculoskeletal sarcoma cells;Kusabe et al.;2015;10.3892/ol.2015.3506;Onclogy Letters;1,482;not reported at all;Penicillin + Streptomycin;Other source;not reported;medium without DMSO;NA;3500;NA;NA;NA;FALSE;other;not reported;SD;reported;FALSE;other;50-100;NA;NA;TRUE;5;0;0,5625;FALSE;1;0,01;Relative cell viability;FALSE;TRUE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingff2133b8-10bc-415d-b23a-e4327f028d59;Effect of temozolomide on the viability of musculoskeletal sarcoma cells;Kusabe et al.;2015;10.3892/ol.2015.3506;Onclogy Letters;1,482;not reported at all;Penicillin + Streptomycin;Other source;not reported;;FALSE;3500;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;other;50-100;NA;NA;TRUE;5;1000;0,5625;FALSE;0,27;0,18;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingff2133b8-10bc-415d-b23a-e4327f028d59;Effect of temozolomide on the viability of musculoskeletal sarcoma cells;Kusabe et al.;2015;10.3892/ol.2015.3506;Onclogy Letters;1,482;not reported at all;Penicillin + Streptomycin;Other source;not reported;;FALSE;3500;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;other;50-100;NA;NA;TRUE;5;125;0,5625;FALSE;0,69;0,41;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingff2133b8-10bc-415d-b23a-e4327f028d59;Effect of temozolomide on the viability of musculoskeletal sarcoma cells;Kusabe et al.;2015;10.3892/ol.2015.3506;Onclogy Letters;1,482;not reported at all;Penicillin + Streptomycin;Other source;not reported;;FALSE;3500;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;other;50-100;NA;NA;TRUE;5;250;0,5625;FALSE;0,55;0,26;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missingff2133b8-10bc-415d-b23a-e4327f028d59;Effect of temozolomide on the viability of musculoskeletal sarcoma cells;Kusabe et al.;2015;10.3892/ol.2015.3506;Onclogy Letters;1,482;not reported at all;Penicillin + Streptomycin;Other source;not reported;;FALSE;3500;NA;NA;FALSE;NA;other;not reported;SD;reported;FALSE;other;50-100;NA;NA;TRUE;5;500;0,5625;FALSE;0,44;0,28;Relative cell viability;FALSE;FALSE;not reported;not reported;not reported;not available;calculation transparent;number clear;no data missing;no data points missing
